SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
--- ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
|X| SECURITIES EXCHANGE ACT OF 1934
---
For the fiscal year ended December 31, 1996
(Mark One) OR
---
| | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
--- SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________ to __________
Commission File Number: 34-19218
--------
PROJECTAVISION, INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 13-3499909
- -------------------------------- ---------------------------------
(State or other jurisdiction (IRS Employer Identification No.)
of incorporation or organization)
Two Penn Plaza, Suite 640
New York, New York 10121
- ------------------------- --------
(Address of principal Zip Code
executive offices)
(212) 971-3000
--------------
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Title of each class
-------------------
Common Stock, Par Value $.0001 Per Share
Redeemable Warrants
Series B Preferred Stock
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
--- ---
YES |X| NO | |
--- ---
Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [ X ]
On March 13, 1997, the aggregate market value of the voting stock held
by non-affiliates of the Registrant was $ 34,098,839 based upon the average of
the closing bid and asked prices of $ 2.065 as of March 13, 1997.
As of March 13, 1997, 16,512,755 shares of the Registrant's
Common Stock were outstanding.
Documents Incorporated By Reference
Document Where Incorporated
- -------- ------------------
None. N/A
PART I
Item 1. BUSINESS.
General
The Company was formed to capitalize on, and generate revenues and
profits primarily from a) the licensing of its proprietary patents, inventions,
systems and technologies to manufacturers and b) the manufacture and sale of
products based on its technology. The Company's first commercial video
production system, its Digital Home Theatre(TM), is currently in production. The
Company is in the business of identifying, developing, patenting, supporting,
manufacturing and marketing technical innovations in the electronic display and
information industry.
Video Projector
The Company's technologies utilize liquid crystal displays (LCDs) and
the new Texas Instruments Digital Light Processing (DLP) light engines as image
sources in concert with the Company's proprietary dual-use projection system.
This new generation technology differs significantly from conventional cathode
ray tube ("CRT") technology, which has been used for the past fifty years in
virtually all television and video systems. The Company anticipates that its
technologies will be capable of producing giant screen displays that are bright
and sharp, have rich color saturation and high contrast. The Company is the
owner of five (5) United States patents, covering its technologies, and
twenty-two (22) foreign patents around the world. Additional patent applications
were filed by the Company in the United States in 1995 with respect to the
Company's proprietary technologies. In addition, the Company has also filed for
further patent protection in various foreign countries for improvement to its
technologies and for protection of related technologies.
The Company's patented technologies utilize LCDs and the Digital
Micromirror Device ("DMD") developed by Texas Instruments as image sources in
concert with the Company's dual-use proprietary projection system. These new
generation solid state technologies differ significantly from conventional CRT
technology, which has been used for the past fifty years in virtually all
television and video systems.
The Company has produced production prototypes of its Texas
Instruments-based DMD projector and demonstration prototypes of its patented
small, lightweight, solid state LCD television projector (the "Projectors"). The
Company has also produced production prototypes of its patented dual-use
front/rear screen
projection television, which incorporates the Projector, known as the "Digital
Home Theater (formerly the "Chameleon(TM)"). The Projector (either incorporated
in the Digital Home Theater or standing alone) is capable of producing bright,
full-color, high-quality television images. The Company has formed a
non-exclusive strategic corporate alliance and entered into an OEM Agreement
with Texas Instruments with respect to the Digital Home Theater. Specifically,
this strategic alliance relates to the manufacture and distribution of the
Digital Home Theater that will incorporate the DMD, which is a component of the
DLP that has been developed by Texas Instruments. The Company has also entered
into arrangements with third parties for the manufacture and production of its
video projection systems which currently include the Projector and the
proprietary Digital Home Theater mechanical and electronics designs.
The Company intends to enter into arrangements with third parties for
the marketing and distribution of its video projection systems. The Company has
licensed, on a non-exclusive basis, its patented "depixelization" micro-optics
which is applicable to a wide range of video projection systems, to Matsushita
Electric Industrial Co., a Japanese company that distributes consumer electronic
products in the U.S. under the Panasonic brand name, and to Samsung Electronics
Co., a Korean company that distributes products under the Samsung brand name.
These non-exclusive licenses offer consumer electronics manufacturers the right
to use certain of the Company's patented technologies. The Company is seeking to
enter into similar, non-exclusive patent license agreements for its
depixelization and other technologies with other parties in a variety of
markets. In addition to licensing its technologies for potential application in
the television market, the Company also intends to offer licenses of its video
projection technologies to commercial and military users. Other potential
markets for the Company's technologies include medical imaging, CAD/CAE
workstations, large format computer monitors, arcade games, video interactives,
home shopping, video teleconferencing, sports entertainment viewing, education,
training and advertising.
The Home Television Market
The Company believes that one of the fastest growing segments of the
color television market is Big and Giant screen televisions, which are defined
as having a diagonal measurement greater than 27 inches and 32 inches,
respectively. The size of the home consumer television market in the U.S. in
1996 exceeded 25 million televisions. Sales of large screen televisions
increased approximately 29% in 1995 and 8% in 1996. It is this growing market
segment of large screen televisions that the
2
Company is targeting. Almost all existing big screen color television screens
rely on CRT-based technology. Big and giant screen televisions produce images in
either direct-view, front projection or rear projection formats. In front
projection, the projector is placed in front of the screen or surface on which
the images are to be displayed, as is typically done with a slide or movie
projector. In rear projection, the projector is placed in an enclosed cabinet
and its video projection illuminates the back of a translucent screen.
Direct-view CRT television currently can produce up to a 40" picture. Rear
projection CRT televisions are capable of producing 80" diagonally measured
pictures. Front projection LCD and DLP projectors can produce giant screen
images up to 20 feet in size measured diagonally. The LCD and DLP solid state,
tubeless projectors are smaller, and lighter weight than either direct-view, or
rear projection models, and do not require a large dedicated space in the home.
Direct-view televisions are capable of producing superior images than most
existing front and rear projections systems. The Company believes that its
technologies will be capable of producing giant screen images in both front and
rear projection formats that will match or exceed the brightness of those
produced in current screen projection systems. The Company's Digital Home
Theatre, driven by Texas Instruments' DMD/DLP technology, provides SVGA
resolution and performs as a giant screen computer monitor.
CRT Technology
Most existing color televisions up to 35 inch screen size are CRT
systems, the basis of virtually all televisions produced since the 1940s. CRT
technology has certain inherent limitations for production of big screen picture
displays, including size, weight and vacuum. As a practical matter, CRT
television is not manufacturable in sizes exceeding 40 inches.
The cost of producing cathode ray tubes and other aspects of the CRT
technology used for big screen display is high. As a result, CRT-based big
screen television generally is disproportionately more expensive than small
screen size television.
The Company's Technologies
The Company's LCD and DLP projection technologies combine the Company's
patented optical and electronic processing systems with high brightness light
sources and solid-state LCD panels, which serve as light valves. Use of LCDs and
DLPs eliminate the cathode ray tube, which in big screen televisions is large,
bulky, heavy and fragile. LCD panels and DMD semiconductors do not pose the
health hazards of CRTs and are smaller, more
3
compact, lighter and less fragile than cathode ray tubes. In reproducing images
in color, CRTs generate X-ray radiation that may be harmful to persons who view
the images at close range over long periods of time. Further, CRTs generate
electro-magnetic fields of considerable magnitude. The physiological effects of
these fields on persons who view the screens at close range is still under
study. The use of LCDs or DMDs in the Company's projection systems will not
result in the generation of X-rays or intense electro-magnetic fields.
LCD television technology was first developed approximately 19 years
ago. Unlike CRT technology, which is a mature technology that has been used for
approximately the past 50 years in virtually all television and video projection
systems, LCD technology is still being significantly refined and improved.
Management anticipates that LCDs, like other solid-state devices, ultimately
will be made more compact, durable, efficient and inexpensive. Like CRT-based
color televisions, LCD-based color televisions are capable of displaying 525
scanning lines and 330 lines of resolution using standard NTSC broadcast
signals. Since the Company's Projector will utilize commercially available
LCD's, the resolution of its picture will be comparable to the resolution of
other standard systems. LCD projection technologies presently contain certain
inherent image quality limitations. The Company's patented technologies are
designed to overcome these limitations and produce an image offering continuous
tone photographic effect enabling substantially increased viewer perception of
image quality when compared with LCD televisions that do not utilize the
Company's depixalization system. The Company believes that its technologies
overcome limitations in current LCDs that might otherwise limit the use of LCDs
for standard NTSC and high definition television ("HDTV") displays and will
improve the ability to display images comparable in quality to those currently
produced by CRT-based projectors. A DLP projector combines DMD microchips with
digital signal processing, memory, software, optical components, and an
illumination source to create extremely bright, high resolution (SVGA) display
systems.
4
The Company is aware of the development by other companies of
innovative flat panel and television systems. These technologies do not use CRT
or projection to produce an image, but instead rely on other technologies
including plasma, thin film electro-luminescence, solid-state lasers, light pipe
systems, vibrating mirror systems, cold cathode screens, PLZT, FED (field
emission display) and others.
The Projector
The Company's Projector, which can be used in front and rear projection
configurations and employs the Company's patented technologies, has the
additional features described below:
Picture Size - The picture size produced by an LCD and DLP television
Projector using a front projection format can be varied continuously to exceed a
20 foot diagonal picture by changing the projection distance or adjusting the
Projector's built-in zoom lens which allows 100% image size magnification.
No Misconvergence - As a result of its single point image source,
neither the LCD or DLP Projector requires alignment or convergence adjustment,
which are required in CRT three lens projection television systems.
Misconvergence is a common problem encountered in present video projectors that
use CRTs, and can occur during shipping or moving of a projection system.
Picture Quality - The Projector is capable of displaying large size
images that show rich color saturation and high contrast and that are visible on
a screen or white painted surface. Images displayed by the Company's
demonstration prototype LCD Projector produces a continuous tone photographic
effect enabling substantially improved image quality, which is the result of the
virtual elimination of visible pixel structure.
Size - The LCD Projector is intended to be small and lightweight,
self-contained and portable, slightly larger than an ordinary shoe box and
weighs less than fifteen (15) pounds. The Company expects that, when produced
for sale, the Projector will be similar in size and weight, thus enabling the
consumer to purchase only one Projector which may be carried easily from room to
room or placed into multiple Digital Home Theatre-type systems in different
rooms or homes.
5
Other Features - The Company's Projector has a built-in television
receiver and audio system, UHF and VHF tuning, and will be connectable to cable
television or to an external antenna and may be operated by remote control. The
Projector will be connectable to video games, video cassette recorders (VCRs),
video disc players, home computers and the new DSS satellite systems.
The Digital Home Theater
As noted above, the Company's first commercial video projection system
will be the Digital Home Theater (formerly "The Chameleon"), a giant screen
consumer product that will incorporate the Company's Projector and the DLP
technology development by Texas Instruments. The Digital Home Theater, which is
currently in production, will be 60" diagonal television that is a rear screen
projection system that can also be used in a front projection configuration.
Specifically, the Digital Home Theater's picture will be generated by the
Company's lightweight, portable Projector, which can easily be removed by the
consumer so that the Projector itself can be carried to a different location and
be used to project an image on a wall, screen, or ceiling. The Digital Home
Theater itself, which includes the Projector, is a relatively lightweight,
easily assembled cabinet with a screen that is 60" in diagonal and 23" thick
(front-to-rear measurement), and is a patented design of the Company.
Markets
As noted above, the Company believes that one of the fastest growing
segments of the color television market is big and giant screen televisions,
which are defined as having a diagonal measurement greater than 27 inches and 32
inches, respectively. The size of the home consumer color television market in
the U.S.
in 1996 exceeded 25 million televisions.
It is this fast growing market segment of large screen televisions that
the Company is targeting. In addition to the large screen home consumer market,
the Company will seek to develop its projection technology for application in a
variety of other markets. Described below, in no particular order, are some of
the other video display markets to which the Company believes its projection
technologies may be particularly suited. However, there can be no assurance that
the Company will be able to successfully develop products for use in these or
any other areas.
o Military/Federal - including land and ship command and
control centers; in field briefing; cockpit instrumentation for
6
aircraft, ships and land vehicles; intelligence community uses; archival storage
and retrieval systems.
o Commercial/Office - product and sales demonstrations; seminars;
replacement of CRT computer monitors.
o Computer Monitors - replace CRT's for large screen use by groups of
people.
o CAD/CAM - computer assisted design and computer assisted
manufacturing, including large image computer work stations.
o Medical Imaging - on site and offsite diagnostic functions; large
screen surgical demonstration.
o Video Teleconferencing - business meetings and product
demonstrations.
o Education and Training - classroom and large audience presentations.
o Movie Theater and Sports Bars - sports and other entertainment
viewing.
Research and Development
From the Company's inception in September, 1988 through December 31,
1996, the Company has invested approximately $5,800,000 for research and
development of its technology. The Company has constructed production prototypes
and completed substantially all research and development activities in
connection with the Projector and the Digital Home Theater, although certain
refinements are still ongoing, including optimizing picture brightness. The
Company has and continues to explore the feasibility of using light valves other
than LCDs in its projection technologies.
Manufacturing, Marketing, Licensing and Other Activities
With respect to the Digital Home Theater, the Company is engaged in
discussions with national audio-video retailers who have expressed an interest
in distributing the Company's manufactured product. The Company also intends to
market its patented technologies to major consumer electronics
manufacturers/marketers.
7
Texas Instruments Memorandum of Understanding
In September, 1996 the Company entered into an OEM agreement between
the Company and Texas Instruments to incorporate Texas Instruments' DLP
projection technology for use in the Company's consumer projection television
system, the Digital Home Theater. The Digital Home Theater, which will feature
projection technologies from both the Company and Texas Instruments, is a single
system that has both front and rear projection capabilities as well as offering
standard or wall-sized images for television and Super VGA computer displays.
Samsung License
In November, 1994, the Company entered into a non-exclusive license
agreement with Samsung Electronics Co. of South Korea, providing Samsung the
right to use the Company's patented depixelization and brightness video
projection technology. Samsung Group is one of Korea's largest industrial
companies. The disclosure of the terms and conditions of the Samsung License are
expressly subject to strict confidentiality provisions set forth in such
license.
Matsushita License
In March, 1993, the Company entered into a patent license agreement
with Matsushita Electric Industrial Co., Ltd. ("Matsushita") which granted
Matsushita the right to use the Company's patented depixelization video
projection technology in connection with the manufacturing and marketing of an
advanced tubeless consumer television system in the United States (the
"Matsushita License"). Matsushita distributes consumer electronics products in
the United States under the brand names "Panasonic," "Quasar" and "Technics."
The disclosure of the specific terms and conditions of the Matsushita License,
are expressly subject to strict confidentiality provisions set forth in the
Matsushita License.
Tamarack Investment
In April, 1993, the Company entered into an agreement with Tamarack
Storage Devices, Inc. ("Tamarack"), a spin-off development stage company of the
Microelectronics and Computer Technology Corporation, a research consortium of
leading U.S. technology companies of which the Company is a member. Tamarack
which was established to commercialize holographic storage technology for
various uses such as for the personal computer
8
workstation, commercial storage and the consumer electronics market. Pursuant to
the April 1993 agreement, the Company acquired approximately 37% of Tamarack's
issued and outstanding voting securities. In addition, since Tamarack did not
achieve certain revenue benchmarks by the end of the first calendar quarter of
1995, the Company exercised its right in March, 1996 to purchase, for minimal
consideration, additional shares of Tamarack's Common Stock such that upon
effecting such purchase, the Company assumed ownership of approximately 52% of
Tamarack's issued and outstanding voting securities.
In May, 1994, the Company loaned Tamarack an additional $1,500,000 and
in connection therewith also received warrants to purchase additional shares of
Tamarack's common stock, the precise amount of which is dependent upon the
timing and pricing of a future equity offering by Tamarack. From August through
December of 1995, the Company advanced an aggregate of an additional $97,339
either directly to or for the benefit of Tamarack for general working capital
purposes. Due to Tamarack's inability, to date, to commercialize its holographic
storage technology and Tamarack's current lack of prospects, the Company has
recorded a reserve against its entire investment in Tamarack, including the loan
of $1,500,000. In November, 1996, the Company loaned Tamarack an additional
$100,000 which has not been reserved, since repayment is to be made in 1997 out
of funds coming from the United States Government's Advanced Research Projects
Agency ("ARPA"). Presently Tamarack is participating in a Dept. Of Energy Crada
Award with the Los Alamos National Laboratory in Los Alamos, New Mexico to
develop the recording media necessary to produce holographic recordings.
Proprietary Rights
Projectavision is the owner of five (5) United States patents and
twenty-two (22) foreign patents in a number of countries and has patent
applications pending in numerous industrialized nations around the world. The
Company has filed for further patent protection in the United States and in
various foreign countries for improvements in its technologies. Specifically in
1995, the Company filed separate patent applications covering its thin screen
system, collimation increasing means, light splitting means, input lens arrays
on opposite sides of the image forming element, double input lens array, real
illumination polarized screen and brightness enhancing technologies.
Applications covering such technologies have also been filed in Canada, China
(People's Republic), Europe (E.P.O.), India, Japan, Mexico, South Korea and
Taiwan. Also in 1995, three additional "design" patent applications were filed
in the United States covering
9
Projectavision's rear screen technology systems. Rear screen technology utility
applications were also filed in Canada, China (People's Republic), Europe
(E.P.O.), India, Japan, Mexico, South Korea and Taiwan. Notwithstanding the
Company's patent or pending patent applications, there can be no assurance that
others have not developed such technologies without the Company's knowledge, or
that such pending applications will be allowed or that others will not
independently develop similar technologies, duplicate the Company's technologies
or design around the patented aspects of the Company's technologies. Even though
the Company has been issued patents, challenges may be instituted by third
parties as to the validity, enforceability and infringement of the patents. In
the event that if others are able to design around the Company's patents, the
Company's business could be materially and adversely affected. In addition, in
the event the Company's products are based upon the DLP developed by Texas
Instruments, the Company will also be dependent to a certain extent on the
efficacy of Texas Instruments' patents relative to the DLP, of which there can
be no assurance. The Company has not conducted any independent analysis of the
patents owned by Texas Instruments relating to the DLP.
The cost of the litigation to uphold the validity and enforceability
and prevent infringement of the Company's patents can be substantial. The
Company's patent counsel, Anderson Kill & Olick, PC, has conducted a study to
determine whether the manufacture, use or sale in the United States of the
projector would infringe patents of others. The study reviewed patents covering
active matrix LCDs, optics and LCDs and various electronic and optical
components used in conjunction with such combinations. Counsel has determined
that the combination of features disclosed in the Company's patent application
would not constitute literal infringement of the patents reviewed.
Counsel also has reviewed certain of the patents covered by the literal
infringement study to determine whether the combination of features described in
the Company's application would infringe such patents under the doctrine of
equivalents. Under this doctrine, a product which does not literally infringe a
patent because it does not have all features of any of the patent claims might,
nevertheless, be deemed to infringe such patent, if and only if the difference
between the patented product and accused products are insubstantial. Counsel has
concluded that the combination of features described in the Company's patent
application would not infringe any of the patents included in counsel's doctrine
of equivalents study under the doctrine of equivalents. With respect to those
patents which were not included in the doctrine of equivalents study, counsel
has advised the Company that even if the combination of features described in
the Company's application would infringe such
10
patents under the doctrine of equivalents it is likely that either (i) suitable
non-infringing alternative components would be available, or (ii) the Company
will be able to obtain a license from the owner of such patent. In order for the
Company to obtain such a license it may be necessary for the Company to grant a
cross license of the Company's patent-pending technology to a potential
licensor.
Counsel also has reviewed the patents to determine whether the
components of the Projector set forth in the Company's patents constitute
literal infringement of the other patents reviewed. Counsel has concluded that
the manufacture, use or sale in the United States of the Projector including
such components would not constitute literal infringement of the patents
reviewed; however, Counsel will not be able to determine whether the components
of the Projector would infringe the remaining patents reviewed until certain
components to be used in the Projector are definitively selected. Counsel has
not reviewed the patents to determine whether the components of the Projector
disclosed in the Company's patent application would constitute infringement of
the patents directed to such components under the doctrine of equivalents.
However, counsel has advised the Company that, as a matter of law, any component
purchased from a seller in the normal course of business ("off the shelf") is
purchased with a warranty from the seller that such component does not
constitute literal or equivalents infringement of patents of others. In
addition, counsel has advised that if the Company arranges to have certain
components manufactured to its specifications and, therefore, is not deemed to
have purchased such components off the shelf it is likely that either (i) the
seller of such component will indemnify the Company from patent infringement
claims, or (ii) the Company will be able to obtain a license from the owner of
the patent which is infringed. However, there can be no assurance that the
Company will enter into any such arrangements and if the Company is unable to
enter into such arrangements, its business may be adversely affected.
In some cases, the Company may rely on trade secrets to protect its
innovations. There can be no assurance that trade secrets will be established or
that others will not independently develop similar or superior technologies. The
Company routinely requires employees, Directors, consultants and other third
parties to whom confidential information has been or will be disclosed, to agree
to keep the Company's proprietary information confidential and to refrain from
using such information in any manner that is adverse to the Company's interest.
However, there can no assurance that such agreements will be complied with or
will be enforceable.
11
The Company is the owner of the trade name Projectavision, Inc. This
mark was registered by the United States Patent and Trademark Office on February
4, 1997.
The following Trademark applications have been filed:
TRADEMARK COUNTRIES STATUS
- --------- --------- ------
DHT and DIGITAL U.S.A.,Europe, Japan, Korea, Pending
HOME THEATER Taiwan, India, China, Canada
Mexico, Brazil, Chile, Peru
and Argentina
COMPUTER THEATER U.S.A. Pending
KANGAROO U.S.A. Pending
CHT U.S.A., and Taiwan Pending
COMPUTER HOME THEATER U.S.A., and Taiwan Pending
Generally, pending trademark applications significantly inhibit the
ability of a third party to obtain registration for identical or similar marks
to those of the Company's during the pendency of application. However, the
specific trademark laws in each of the countries vary.
The Company also registered the trademark PROJECTAVISION in Japan on
October 31, 1995. Intent-to-Use applications for this mark have also been filed
in European Countries, Korea, Taiwan, India, China, Canada, Mexico, Chile, Peru,
Argentina and Brazil. In addition to the trademark PROJECTAVISION, the Company
has applied for registration of several Intend-to-Use trademark applications
various countries.
On April 7, 1995, Eugene Dolgoff, a founder of the Company and its
former Chief Scientist, filed suit against the Company alleging, among other
things, certain ownership rights with respect to the Company's technologies. See
Item 3 "Legal Proceedings."
12
Competition
The television and video display industry is highly competitive,
although its patents and technologies are additive, the Company believes that in
many instances it will be directly competitive with consumer electronics
manufacturers. To the extent the Company does encounter competition, most of the
Company's competitors and potential competitors have and will have far greater
financial resources, research and development facilities, manufacturing and
marketing experience, distribution and sales networks, established customer
bases, and greater brand name recognition than the Company currently has.
Although there can be no assurances, the Company expects that it will be able to
compete successfully against its competitors on the basis of its proprietary
projection technologies and patent portfolio, product size and weight, price and
picture quality. The Company plans to enter into arrangements for the
manufacture, marketing and distribution of the television Projector with third
parties which have established capabilities in those areas. However, there can
no assurance that the Company will be able to compete successfully or enter into
or maintain such arrangements on acceptable terms or at all.
The Company is aware of other companies who have developed projection
technologies that may function without the Company's principal technologies, and
may become competitive, including Everex(R), Comtech/RAF/Flask(R), Kopin(R),
Kuraray(R), Microsharp/Nashua(R), and others. In addition, other companies are
developing variations of video projectors which may not necessarily rely on the
Company's technologies for image improvement. These include Sharp
Corporation(R), GE(R), Telex(R), Epson(R), Toshiba(R), Hitachi(R), Sanyo(R),
JVC(R), Philips(R), Eiki(R), Infocus(R), In-View(R), Proxima(R), 3M(R) and
others. Although the Company believes that its projection technologies (and
those technologies of Texas Instruments to be employed with the Digital Home
Theatre) have distinct advantages over the technologies developed by these
companies, there can be no assurance that the Company's competitors have not or
in the future will not develop technologies, projectors and other products that
are of the same or better quality than those developed and produced by the
Company. There can be no assurance that the Company will be able to overcome the
far greater financial resources, manufacturing, distributing, marketing, sales
and other resources of these competitors.
In addition to development of the Digital Home Theater and the
television Projector as a consumer item, the Company intends to pursue other
applications of its projection technologies in a variety of other commercial
industries and markets. Many of these areas are highly competitive. Most of the
Company's competitors and potential competitors in these areas have and
13
will have far greater financial resources, research and development facilities,
manufacturing and marketing experience, distribution and sales networks,
established customer networks, and greater name recognition than the Company
currently has. There can be no assurance that the Company will be able to
overcome these factors.
Government Regulations
The Food and Drug Administration ("FDA") of the U.S. Department of
Health and Human Services regulates television radiation emissions. State and
local governments also may regulate television radiation emissions. Compliance
with these regulations, or exemptions therefrom, will be necessary prior to
commencement of marketing of the Projector and the Digital Home Theater. The
Company believes that the Projector and the Digital Home Theater will comply
with applicable regulations. Current FDA regulations do not require FDA review
or approval prior to the manufacturing or marketing of the Projector or the
Digital Home Theater. If the Company's technology is used in the medical imaging
market, it may have to comply with FDA requirements pertaining to medical
devices, including possible extensive premarketing approval requirements. If the
Company is required to obtain premarketing approval from the FDA, use of the
technology in the medical imaging market could be significantly delayed and the
cost of obtaining such approval could be substantial.
The Company will not be permitted to sell the Projector and the Digital
Home Theater in certain states without obtaining UL listing, which the Company
will seek to obtain.
The Company is unable to predict the extent of any governmental
regulation which might arise from future United States or foreign legislative or
administrative action.
Personnel
As of March 13, 1997, the Company employed twelve (12) persons, all of
whom provide management and administrative services on a full-time basis. The
Company also has consulting arrangements with a number of engineers who assist
the Company in research and development. The Company also employs its Chief
Financial Officer pursuant to a consulting agreement. See "Employment
Agreements."
14
Change in Officers
In February of 1995, Mr. Eugene Dolgoff was terminated as an employee
of the Company and in March of 1995 Mr. Dolgoff was terminated as an officer of
the Company for cause. Subsequently, on April 7, 1995, Mr. Dolgoff filed suit in
the Supreme Court of the State of New York against the Company, certain
directors and employees of the Company alleging, among other things, wrongful
termination and breach of his employment contract. See Item 3 "Legal
Proceedings."
In September, 1996, Martin Holleran, the President and Chief Operating
Officer of the Company since November of 1993, became Chief Executive Officer of
the Company. Upon becoming Chief Executive Officer, Mr. Holleran retained the
title of President, but did not keep the title of Chief Operating Officer. Prior
to September, 1996, Marvin Maslow had been the Chief Executive Officer of the
Company since inception of the Company. Mr. Maslow remains as Chairman of the
Board of the Company. In connection with these executive changes, the Company
entered into new six (6) year employment agreement with each of Mr. Holleran and
Mr. Maslow effective March 1, 1997. See Item 10, "Directors and Executive
Officers of the Registrant."
The Company believes that its employee relations are satisfactory,
notwithstanding a charge of discrimination that was filed against the Company
and settled and which was related solely to the actions of Mr. Dolgoff. See Item
3, "Legal Proceedings."
Item 2. PROPERTIES
The Company presently leases approximately 12,000 square feet of office
space for executive and research facilities at Two Penn Plaza, Suite 640, New
York, NY 10121. These facilities were originally subleased from an unaffiliated
party at a rate of approximately $17,000 per month. The sublease expired on
January 30, 1996, at which time, the Company entered into a direct lease with
the landlord for the same premises until January 31, 1998 at a rent of
approximately $21,500 per month. The Company is presently seeking to extend the
term of its current lease.
Item 3. LEGAL PROCEEDINGS
In January 1996, Mr. and Mrs. Eugene Dolgoff sued the Company and
certain members of the Board of Directors in the Chancery Court in the State of
Delaware, and in connection therewith moved to preliminarily enjoin the
Company's annual stockholders' meeting scheduled for February 29, 1996. The
Dolgoffs alleged, among other things, manipulation of the
15
election process and breaches of the Company's charter documents. The Dolgoffs'
request to preliminarily enjoin the meeting was denied. A settlement agreement
has been entered into between the Company and the Dolgoffs, which includes,
among other things, the Company taking steps to move one of its Directors from
one class to another class so as balance the size of its three (3) classes of
directors. A hearing with respect to the settlement agreement has been scheduled
before the Delaware Chancery Court for May 23, 1997.
In May 1996, two of the eleven purchasers of the convertible debt
issued by the Company in the first quarter of 1996 commenced a lawsuit against
the Company in New York State Supreme Court seeking an order to require the
Company to convert their debt into common stock. After the plaintiff's motion
for summary judgement was dismissed, one of the two purchasers settled their
lawsuit with the Company in October, 1996. The litigation with the other debt
holder remains outstanding. The Company believes that it has meritorious
defenses with respect of all of the remaining debt holder's claims and intends
to vigorously defend the litigation. A motion to discussion for lack of
jurisdiction is currently pending before the U.s. District Court in Florida.
In June 1996, a suit was filed by an individual investor against the
Company and Marvin Maslow alleging fraudulent inducement in connection with the
plaintiff's purchase of the Company's securities. The Company believes that it
has meritorious defenses with respect to all of the plaintiff's claims and
intends to vigorously defend the litigation. A motion to dismiss for lack of
jurisdiction is currently pending before the U.S. District Court in FLorida.
In April 1995, the Company and Jules Zimmerman, Richard Hickok, Dr.
Craig Fields, Marvin Maslow, Martin Holleran, and Sherman Langer (in his
capacity as an employee of the Company) were sued by Eugene Dolgoff, a former
officer, Director and employee of the Company in New York State Supreme Court.
Mr. Dolgoff alleged claims for breaches of his employment agreement, wrongful
discharge, tortious interference, libel and slander, declaratory relief with
respect to the ownership of certain of the Company's technologies, claiming that
he has certain rights with respect to the Company's technologies, breach of
contract with regard to a patent assignment agreement, a constructive trust or
unjust enrichment, replevin, conversion, to obtain access to corporate records,
and for a declaration regarding his status as an officer, and seeks damages,
punitive damages and equitable relief aggregating in excess of $100 million. In
April of 1996, the New York State Supreme Court issued an order and opinion
which (i) disqualified the Company's litigation counsel, Anderson, Kill & Olick,
P.C. ("Anderson, Kill") on the basis that Anderson, Kill had a conflict of
interest vis-a-vis Mr. Dolgoff, (ii) substantially denied the Company's motion
to dismiss Mr.
16
Dolgoff's entire complaint, and (iii) denied Mr. Dolgoff's motion to have a
receiver appointed.
The Company appealed the New York Supreme Court's decision regarding
the disqualification of Anderson, Kill and the denial of its motion to dismiss
Mr. Dolgoff's complaint. Mr. Dolgoff appealed the New York Supreme Court's
denial of his motion to have a receiver appointed. In January of 1997, the
Supreme Court of the State of New York Appellate Division First Department (the
"First Department") affirmed the lower court's disqualification of Anderson,
Kill, and the lower court's denial of the Company's motion to dismiss, but also
ordered that a receiver be appointed to protect whatever interest, if any, Mr.
Dolgoff may ultimately be able to prove that he has in any of the inventions
that Mr. Dolgoff assigned to the Company. At the present time, neither the
nature, nor scope, nor authority, nor term of the receivership has been
determined, all of which will be decided by the New York State Supreme Court,
which initially denied Mr. Dolgoff's motion for a receivership. In addition, at
this time, neither the Appellate Court, nor any other court, has determined that
Mr. Dolgoff has any proof to support his claims; the Appellate Court has merely
reaffirmed the lower court's decision that, at this preliminary stage of the
litigation, Mr. Dolgoff's complaint has satisfied procedural pleading
requirements. The Company, which vigorously denies all of Mr. Dolgoff's
allegations, believes that it has meritorious defenses with respect to all of
Mr. Dolgoff's claims and intends to vigorously defend the litigation. Moreover,
since the institution of the litigation by Mr. Dolgoff, new facts have come to
the attention of the Company. As a consequence, the Company intends, in the near
future, to seek leave from the Court to amend its pleadings and file
counterclaims against Mr. Dolgoff, his affiliated companies, Breakthrough
Enterprises, Inc. and Floating Images, Inc., and members of the board of
directors of those entities, for fraud, breach of fiduciary duty,
misappropriation of trade secrets, conversion, breach of contract, diversion of
corporate assets and opportunities, unjust enrichment, and tortious interference
with contractual relations. The Company also intends, in connection with
amending its pleadings, to seek injunctive relief and a constructive trust, in
addition to monetary damages in excess of $200 million from Mr. Dolgoff and
others.
In June of 1995 and August of 1995, two class action suits were filed
against the Company as well as certain of its officers and directors by
stockholders of the Company. In October of 1995, the plaintiffs in the second
action joined as plaintiffs in the first action and the second action was
dismissed without prejudice. In July 1996, the class action suit was dismissed
without prejudice and the plaintiffs were given an opportunity to replead. New
pleadings have now been submitted to the Court by
17
the plaintiffs. The class action suit now alleges numerous violations of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), including, but
not limited to, violations of Section 10(b) of the Exchange Act. The suit also
alleges claims for common law fraud and deceit. In response, the Company and the
individual defendants have submitted motions to dismiss the action. These
motions are pending before the Court.
Except as set forth above, the Company is not presently a party to any
litigation nor, to the knowledge of management, is any material litigation
threatened against the Company.
Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
Not applicable.
18
PART II
Item 5. MARKET FOR REGISTRANT'S COMMON
EQUITY AND RELATED STOCKHOLDER MATTERS
The Company's Common Stock, Redeemable Warrants and Series B Preferred
Stock are quoted on NASDAQ under the following symbols:
Common Stock: PJTV
Redeemable Warrants: PJTVW
Series B Preferred Stock: PJTVP
The Common Stock and Redeemable Warrants were initially registered and
traded as Units and were not separately transferrable until August 24, 1991. The
Units commenced trading in the over-the-counter market on the closing of the
Company's initial public offering on August 1, 1990.
On February 27, 1992 the Company announced a two-for-one stock split,
effective March 2, 1992. Accordingly, all quoted prices for the Company's
securities commencing with the first quarter of 1992 are adjusted to reflect the
March 1992 two-for-one stock split.
The Series B Preferred Stock was initially registered on September 9,
1992 in connection with the Company's Redeemable Warrant incentive program (the
"Warrant Incentive Program"). Prior to that time, there was no public market for
the Series B Preferred Stock. Pursuant to the Warrant Incentive Program, holders
of the Company's Redeemable Warrants who exercised their Redeemable Warrants
within 65 days after September 9, 1992 received one (1) share of Series B
Preferred Stock for every three (3) Redeemable Warrants exercised. In connection
with the Warrant Incentive Program, the Company issued 246,452 shares of Series
B Preferred Stock.
The Common Stock, Redeemable Warrants and Series B Preferred Stock of
the Company are traded in the over-the-counter market and are quoted on the
NASDAQ inter-dealer automated quotations system. There is no public trading
market for the Company's Series A Preferred Stock (of which there is only one
(1) holder), Series C Preferred Stock (of which there is only one (1) holder),
or Series D Preferred Stock (of which there are only two (2) holders). The high
and low bid quotations for the Common Stock, Redeemable Warrants and Series B
Preferred Stock for each full quarterly period for the fiscal years ending
December 31, 1995 and December 31, 1996 and for the first quarter of 1997
through March 13, 1997 are listed below:
19
COMMON STOCK WARRANTS PREFERRED STOCK
1995 Calendar Quarter Quoted Bid Price Quoted Bid Price Quoted Bid Price
- --------------------- ---------------- ---------------- ----------------
High Low High Low High Low
---- --- ---- --- ---- ---
First Quarter 3.67 2.50 4.17 2.67 4.00 3.04
Second Quarter 3.30 1.81 3.17 1.33 3.58 2.29
Third Quarter 3.90 2.54 4.38 2.50 4.13 2.92
Fourth Quarter 5.52 3.44 7.83 5.33 5.83 4.25
COMMON STOCK WARRANTS PREFERRED STOCK
1996 Calendar Quarter Quoted Bid Price Quoted Bid Price Quoted Bid Price
- --------------------- ---------------- ---------------- ----------------
High Low High Low High Low
---- --- ---- --- ---- ---
First Quarter 4.56 4.00 5.25 5.00 6.00 5.00
Second Quarter 3.56 2.19 4.00 3.25 4.00 3.00
Third Quarter 4.00 2.81 6.13 4.25 4.50 4.00
Fourth Quarter 3.69 2.56 6.50 5.50 3.50 2.75
COMMON STOCK WARRANTS PREFERRED STOCK
1997 Calendar Quarter Quoted Bid Price Quoted Bid Price Quoted Bid Price
- --------------------- ---------------- ---------------- ----------------
High Low High Low High Low
---- --- ---- --- ---- ---
First Quarter (through
March 13, 1997) 3.47 2.00 5.50 2.00 3.75 2.25
On March 13, 1997 the closing bid and asked prices of Common Stock as
reported on the NASDAQ system were $2.00 and $2.13 per share, respectively. On
March 13, 1997, the closing bid and asked prices of Warrants as reported on the
NASDAQ system were $2.00 and $4.00 per Warrant, respectively. On March 13, 1997,
the closing bid and asked prices of Series B Preferred Stock on the NASDAQ
system were $2.25 and $2.63, respectively.
On March 13, 1997 there were 408 holders of record of Common Stock and
16,512,755 shares of Common Stock issued and outstanding; 4 holders of record of
Redeemable Warrants and 36,133 Warrants issued and outstanding; and 7 holders of
record of Series B Preferred Stock and 351,258 shares of Series B Preferred
Stock issued and outstanding.
No cash dividends have been paid by the Company and management does not
anticipate paying cash dividends in the foreseeable future.
20
Item 6. SELECTED FINANCIAL DATA
The selected financial information set forth below is derived from the
more detailed financial statements and related notes thereto included elsewhere
in this Annual Report on Form 10-K. This information should be read in
conjunction with such financial statements and related notes.
Statements of Operations Data
For the Period
September 9,
1988 (Date of
Incorporation)
For the Years Ended December 31, to December 31,
1992 1993 1994 1995 1996 1996
----------- ------------ ----------- ----------- ----------- --------------
Revenues $ -0- $ 105,000 $ -0- $ 200,000 $ 150,000 $ 1,455,000
Research and
Development $ 346,797 $ 276,215 $ 827,660 $ 608,651 $ 2,389,329 $ 5,811,252
Net Loss $(2,002,795) $(2,730,242) $(5,632,283) $(6,471,638) $(9,047,560) $(29,368,430)
Net Loss per Share Attributable to Common
Shareholders $ (.27) $ (.26) $ (.47) $ (.51) $ (.86)
Average Number of Shares
Outstanding 7,324,332 10,449,499 11,895,648 12,606,678 13,586,705
21
Balance Sheet Data
December 31,
------------------------------------------------------------------------------------------------------
1992 1993 1994 1995 1996
---- ---- ---- ---- ----
Working capital $ 4,346,665 $ 5,181,003 $ 6,659,132 $ 3,341,425 $ 3,421,387
Total assets $ 4,508,374 $ 8,300,501 $ 9,850,523 $ 4,168,415 $ 10,132,488
Total liabilities $ 162,620 $ 390,580 $ 236,473 $ 485,710 $ 3,690,443
Accumulated deficit $(5,486,707) $(8,216,949) $(14,015,013) $(20,641,044) $ (32,323,935)
Stockholders' $ 4,345,754 $ 7,909,921 $ 9,614,050 $ 3,682,705 $ 6,442,045
equity
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following management discussion and analysis should be read in
conjunction with the financial statements and notes thereto in Item 14 hereof.
Liquidity and Capital Resources
As of December 31, 1996, the Company had working capital of $3,421,387.
To date, the Company has funded its operations primarily from sales of capital
stock.
In February, 1996, the Company completed a private placement of convertible
debt of $10.0 million which resulted in $9.5 million in net proceeds to the
Company after paying a 5% investment banking fee. The unsecured debt requires
quarterly interest payments in cash based upon an annual interest rate of 8%.
The debt matures in three (3) years, at which time any convertible debt then
outstanding is to be repaid by the Company in cash or common stock, at the sole
option of the Company.
The Company intended to use the proceeds from this offering principally
in connection with the commencement of the production and introduction of its
Digital Home Theatre.
In June, 1996, the Company completed a private placement of 7,500 shares
of a newly created Series C Convertible Preferred stock for $ 7.5 million which
resulted in net proceeds to the Company of $7 million after paying investment
banking fees. The proceeds of this private placement were used primarily to
retire unconverted portions of the convertible debt which the Company issued in
February of 1996. There currently remains $1.5 million of convertible debt as of
March 13, 1997, all of which is held by one entity with whom the Company is
currently in litigation. See Item 3 "Legal Proceedings." At the present time,
5,625 shares of this Series C Preferred Stock are eligible for conversion (4,210
of which have been converted into an aggregate of 2,226,186 shares of the
Company's Common Stock) and the remaining 1,750 shares of Series C Preferred
Stock will be eligible for conversion on Mary 1, 1997. All shares of Series C
Preferred Stock are convertible at a 25% discount to the then current market
price of the Company's Common Stock at the time of conversion (the "Series C
Conversion Price"); provided, however, that in the event that the Series C
Conversion Price is less than $1.50 per share, then under no circumstances can
shares of Series C Preferred Stock be converted into the Company's Common Stock
until such time as the Series C Conversion Price exceeds $1.50 per share,
subject to the following: (i) in the event that the Company fails to either ship
2,500 projectors or generate
23
$12,500,000 in projector revenues during the period January 1, 1997 through June
30, 1997, then the Series C Conversion Price shall be reduced by $.50, or (ii)
in the event that the Company fails to ship 2,500 projectors and generate
$12,500,000 of projector revenues during the period July 1, 1997 through
December 31, 1997, then the Series C Conversion Price shall be reduced by $.50.
In January of 1997, the Company issued an aggregate of 35,000 shares of
6% Series D convertible preferred stock to two foreign institutional investors
for an aggregate purchase price of $3,500,000, resulting in net proceeds to the
Company of $3,500,000. Each share of Series D Preferred Stock is convertible, at
the option of the holder, into shares of the Company's Common Stock as follows:
8,750 shares on or after May 1, 1997; 8,750 shares on or after July 1, 1997;
8,750 shares on or after September 1, 1997; and 8,750 shares on or after
November 1, 1997. The Series D Preferred Stock is convertible into Common Stock
at a 25% discount to the then current market price of the Company's Common Stock
at the time of conversion (the "Series D Conversion Price"); provided, however,
that in the event that the Series D Conversion Price is less than $2.00 per
share, then under no circumstances can shares of Series D Preferred Stock be
converted into the Company's Common Stock until such time as the Series D
Conversion Price exceeds $2.00 per share, subject to the following: (i) in the
event that the Company fails to either ship 2,500 projectors or generate
$12,500,000 of projector revenues during the period January 1, 1997 through June
30, 1997, then the Series D Conversion Price shall be reduced by $.50, or (ii)
in the event that the Company fails to ship 2,500 projectors and generate
$12,500,000 of projector revenues during the period July 1, 1997 through
December 31, 1997, then the Series D Conversion Price shall be reduced by $.50.
The Company intends to use the proceeds from this offering principally
in connection with the commencement of the production and introduction of its
Digital Home Theatre.
The Company also intends to rely on arrangements with retailers and
contract manufacturers in connection with meeting the balance of the capital
requirements necessary for the Company to manufacture, market and distribute the
Digital Home Theater.
The Company is in the development stage and, to date, its sole revenues
have been $1,455,000. Of such revenues, $1,000,000 were derived from a
government agency to develop certain projection technology for use in a high
definition television projector and the balance, $455,000, from licensing
agreements. The Company has substantially completed research and development
with respect to the Digital Home Theatre and the Projector, and,
24
consequently, the Company does not presently anticipate that any significant
expenditure of funds for research and development is necessary in order to
complete the Digital Home Theater and the Projector, although certain
engineering refinements are still ongoing, including optimizing picture
brightness for a new rear projection system. The Company is also expending
research efforts in connection with testing the feasibility of the Company's
thin screen. In addition, due to the inability of the Company's affiliate,
Tamarack Storage Devices, Inc., to commercialize its holographic storage
technology and Tamarack's current lack of prospects in the near future, the
Company determined in the fourth quarter of 1996 to record a reserve of
approximately $2,100,000 against its entire interest in Tamarack. The Company
loaned Tamarack and additional $ 100,000 in November, 1996 which has not been
written off, since the funds are to repaid in March 1997 following receipt of
funds from DARPA.
Primarily as a result of work performed in developing its technology,
the Company has sustained losses aggregating approximately $29,368,430 from its
inception to December 31, 1996. The Company has continued to incur losses since
December 31, 1996.
As of December 31, 1996, the Company had available for Federal income
tax purposes net operating and capital loss carryforwards of approximately
$21,000,000. The Internal Revenue Code of 1986, as amended (the "Internal
Revenue Code"), may impose certain restrictions on the amount of net operating
loss carryforwards which may be used in any year by the Company.
Results of Operations
January 1, 1993 to December 31, 1993
The Company had revenues of $105,000 for the twelve month period ended
December 31, 1993, all of which was from licensing agreements. During this
period, the Company incurred cash expenses of $2,111,933. The Company also
incurred non-cash expenses of $380,494 during this period relating to the
issuance of stock for services incurred for salaries paid or payable to officers
and employees of, and consultants to, the Company as compensation for services
rendered to the Company.
January 1, 1994 to December 31, 1994
The Company has no revenue for the twelve months ended December 31,
1994. The Company incurred cash expenses of $3,843,063. The Company also
incurred non-cash expenses of
25
$257,250 during this period relating to the issuance of stock for services
incurred for salaries paid or payable to officers and employees of, and
consultants to, the Company as compensation for services rendered to the
Company. The Company also recorded its proportional share of the loss of
Tamarack of $1,691,697.
January 1, 1995 to December 31, 1995
The Company had revenues of $200,000 for the twelve month period ended
December 31, 1995, all of which was from licensing agreements. During this
period, the Company incurred cash expenses of $3,873,607. The Company also
incurred non-cash expenses of $3,160,138 during this period relating to the
issuance of stock for services incurred for salaries paid or payable to officers
and employees of, and consultants to, the Company as compensation for services
rendered to the Company, and the aforementioned reserve of the Company's
interest in its affiliate, Tamarack Storage Devices, Inc.
January 1, 1996 to December 31, 1996
The Company had revenues of $150,000 for the twelve month period ended
December 31, 1996, all of which was from licensing agreements. During this
period, the Company incurred cash expenses of $6,884,343. The Company also
incurred non-cash expenses of $ 2,071,933 during the period relating to the
issuance of warrants and options as compensation for services rendered to the
Company and for the early retirement of debt. The Company also recorded
$2,357,188 in dividends on the Series C Convertible Preferred Stock in
connection with recognizing the discount on the conversion feature.
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
See Financial Statements following Item 14 of this Annual Report on
Form 10-K.
Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS OR
ACCOUNTING AND FINANCIAL DISCLOSURE
None.
Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
The directors and executive officers of the Company are listed below,
followed by a brief description of their business experience during the past
five years.
Term
26
Name Age Position Expires
- ---- --- -------- -------
Marvin Maslow 59 Chairman of the Board 1999
of Directors
Martin Holleran(1) 54 President, Chief Executive
Officer and Director 1997
Martin D. Fife(1) 69 Director 1997
Craig I. Fields(2) 50 Director 1997
Richard S. Hickok(1) 71 Director 1997
Arthur Lipper III 65 Director 1998
Jules Zimmerman 62 Chief Financial Officer, 1999
Secretary and Director
Sherman Langer 50 Director 1999
- -----------------
(1) Director is being nominated for re-election for a three (3) year term
at the 1997 stockholders' meeting.
(2) Director is being nominated for re-election for a one (1) year term at
the 1997 stockholders' meeting.
Marvin Maslow, a co-founder of the Company, has served as Chairman of
the Board of Directors of the Company since its inception. Mr. Maslow also
served as the Company's Chief Executive Officer from inception through September
30, 1996, when he voluntarily resigned as Chief Executive Officer of the
Company, endorsing the appointment by the Board of Mr. Martin Holleran as Chief
Executive Officer of the Company. Mr. Maslow also served as an officer and a
director of DKY, Inc. ("DKY"), the Company's predecessor in interest from
October 1988 until June 12, 1990, when DKY was merged into the Company. Mr.
Maslow also served as Chief Financial Officer of the Company from its inception
until the consummation of its initial public offering in August, 1990.
27
Martin J. Holleran, has served as President of the Company since
November, 1993. On September 30, 1996, Mr. Holleran became Chief Executive
Officer of the Company, at which time, he retained the title of President but
resigned as the Chief Operating Officer of the Company, a position which he had
also held since November, 1993. Prior to 1993, Mr. Holleran served as President
and Chief Executive Officer of Thomson Consumer Electronics Marketing and Sales
Company ("Thomson") from 1988 to 1992. At Thomson, Mr. Holleran had overall
responsibility for the marketing, sales and distribution of the RCA and GE
brands of consumer electronic products sold in North and South America. From
1992 until 1993, Mr. Holleran was President and Chief Operating Officer of
Emerson Radio.
Martin D. Fife, a founder of the Company, has served on the Board of
Directors since its inception. In addition, Mr. Fife was the Secretary of the
Company from its inception until January 1993. Mr. Fife served as an officer and
a director of DKY from August 1988 until July 12, 1990 when DKY was merged into
the Company. Mr. Fife has been the Chairman of the Board of Directors of Skysat
Communication Network Corporation, a public company, since its inception in July
1992. Since 1987, Mr. Fife has been Chairman of the Board of Magar Inc., a
company of which he is a founder specializing in financial products and the
development of early stage companies. From 1985 to 1989, Mr. Fife was President
of Intergold USA, Inc., a Company involved in the sale and processing of
precious metals. From 1986 to 1989, Mr. Fife was President of Agremp Holdings
Incorporated, an operator of storage elevators. Since April 1992, Mr. Fife has
been a director of the Nova Group, a company engaged in the recycling of
industrial plastics. Since 1974, Mr. Fife has served as a director or trustee of
several investment companies advised by the Dreyfus Corporation, a registered
investment adviser, and currently serves as a director or trustee of the
following thirteen investment companies: The Dreyfus Fund Incorporated, Dreyfus
Liquid Assets, Inc., Dreyfus Municipal Income, Inc., Dreyfus New York Municipal
Income, Inc., Dreyfus California Municipal Income, Inc., Dreyfus Worldwide
Dollar Money Market Fund, Inc., Dreyfus Short-Term Fund, Inc., Dreyfus Short-
Term Income Fund, Inc., Dreyfus Asset Allocation Fund, Inc., Dreyfus Growth
Allocation Fund, Inc., Dreyfus Institutional Short-Term Treasury Fund, Dreyfus
Short-Intermediate Government Fund and Dreyfus Short-Intermediate Municipal Bond
Fund.
Dr. Craig I. Fields has served as a Director since September 1994 and
has been Chairman of the Company's Business and Technical Advisory Board since
January 1, 1993. From April 1989 to April 1990, Dr. Fields was the Director of
the United States Government's Defense Advanced Research Projects Agency
(DARPA). From July 1990 to June 1994, Dr. Fields was the Chairman and
28
Chief Executive Officer of the Microelectronics and Computer Technology
Corporation (MCC). Since September 1994, Dr. Fields has served as Vice Chairman
of Alliance Gaming Corporation (formerly known as United Gaming, Incorporated),
a diversified entertainment company in the gaming industry. Dr. Fields currently
serves as the Chairman of the Defense Science Board, an advisory board to the
Secretary of Defense. Dr. Fields also serves on the Science and Technology
Advisory Panel supporting the Director of Central Intelligence; on the United
States Advisory Council on the National Information Infrastructure; and on the
US-Israel Science and Technology Commission. Dr. Fields is also a member of the
Board of ENSCO, Perot Systems Corporation and Intertech. Dr. Fields is on the
Advisory Boards of SRI International, United Technologies Corporation and the
Economic Strategy Institute. Dr. Fields is also an advisor to SAIC. In 1988, Dr.
Fields was awarded the President's Distinguished Executive Rank Award for
outstanding service, and in 1990 the President's Meritorious Executive Rank
Award.
Richard S. Hickok, a certified public accountant, served as a Director
of the Company from December 1988 to March 1989. Mr. Hickok has continuously
served as a Director of the Company since February 1990. From October 1989 to
December 31, 1996, Mr. Hickok served as an officer, director and stockholder
of Hickok Associates, Inc., a company that provided financial consulting
services ("Hickok Associates"). From 1948 to 1983, Mr. Hickok was associated
with KMG Main Hurdman, Certified Public Accountants in various capacities. Mr.
Hickok served as Chairman of the Board of KMG Main Hurdman from 1981 to 1983,
and in 1983 he retired and was elected Chairman Emeritus. Since 1983 Mr. Hickok
has been a financial consultant. During the past five years Mr. Hickok also has
served as a director of Marsh McLennan Companies, Inc., Comstock Resources,
Inc., Marcam, Inc. and Alpine Lace Brands, Inc.
Arthur Lipper III, is an experienced, independent investment banker and
corporate advisor, and has served as a Director of the Company since March,
1996. He has a particular interest in assisting early stage, growing
enterprises. He is also an established author and lecturer on subjects relating
to investing in and financing businesses. His most recent book is entitled The
Guide for Venture Investing Angels - Financing and Investing in Private
Companies. He is also a strong advocate of independent members of boards of
directors taking an active role in representing the interests of the owners of
the companies in the management of the business. He has been a member of the New
York Stock Exchange and many other stock and commodity exchanges. Mr. Lipper has
been an advisor to the Company and has served on its Business and Technical
Advisory Committee since 1993.
29
Jules Zimmerman has served as a Director since January 1993, as
Secretary of the Company since February 1994 and as the Chief Financial Officer
of the Company since 1990. From October 1989 to December 31, 1996, Mr.Zimmerman
served as President and Chief Executive Officer of Hickok Associates, Inc., a
company that provides financial consulting services ("Hickok Associates"). Mr.
Zimmerman was employed by Avon Products Inc. for 12 years and served as Avon's
Senior Vice President and Chief Financial Officer from 1984 to 1988. From 1992
through 1995, Mr. Zimmerman was a member of the Board of Directors of Winners
All International, as well as its predecessor-in-interest, National Child Care
Company. He is a Director of the GP Financial and was the President of the New
York Chapter of the National Association of Corporate Directors from September
1990 through December 1992.
Sherman Langer has been the Company's Senior Vice President of
Marketing and Sales since October 1994 and has served as a member of the Board
since February, 1996. Mr. Langer was a consultant to the Company from February
1994 until October 1994. From June 1988 through January 1994, Mr. Langer was the
General Manager of the Consumer LCD Products Division of the Sharp Electronics
Corporation.
Broad Classification and Committees and Advisory Board
The Company adopted a classified Board of Directors in February, 1990.
The Board of Directors presently consists of eight members divided into three
classes. In order to realign the classes such that the term of office of each
Director in a given class expires at the third annual meeting of stockholders
following his election, Dr. Fields is being nominated for re-election for a
one(1) year term at the Company's 1997 Annual Meeting. Subsequent to the 1997
annual meeting, the Company will have three (3) Directors whose term expires in
1999, three (3) Directors whose term expires in 2000 and two (2) Directors whose
term expires in 1998. Having a classified Board of Directors may be viewed as
inhibiting a change in control of the Company and having possible anti-takeover
effects. Officers of the Company serve at the discretion of the Board of
Directors.
The Company has an Audit Committee, a Compensation Committee and an
Executive Committee. The Audit Committee reviews the engagement of the
independent accountants, reviews and approves the scope of the annual audit
undertaken by the independent accountants and reviews the independence of the
accounting firm. The Audit Committee also reviews the audit and non-audit fees
of the independent accountants and the adequacy of the Company's
30
internal control procedures. The Audit Committee is presently comprised of
Richard S. Hickok, Jules Zimmerman and Martin D. Fife. The Audit Committee held
one (1) meeting during 1996. The Compensation Committee reviews compensation
issues relating to executive management and makes recommendations with respect
thereto to the Board of Directors. The Compensation Committee is presently
comprised of Jules Zimmerman, Richard Hickok, Martin Fife and Craig Fields. The
Compensation Committee held three (3) meetings in 1996. The Executive Committee
exercises all the powers and authority of the Board of Directors in the
management and affairs of the Company between meetings of the Board of
Directors, to the extent permitted by law. However, the Executive Committee may
not take any action unless a meeting of the Board of Directors cannot be
convened within three days after notice thereof. The current members of the
Executive Committee are Martin D. Fife, Martin Holleran and Marvin Maslow. The
Company formed a Special Executive Committee in 1995 to deal with all matters
relative to certain litigations in which the Company is a defendant. The Special
Executive Committee is not empowered to make any decisions on behalf of the
Board of Directors. The Special Executive Committee is comprised of Marvin
Maslow, Martin Holleran, Martin Fife, Jules Zimmerman, Richard Hickok and Craig
Fields. The Special Executive Committee held one (1) meeting in 1996. The Board
also held four (4) regular and six (6) special meetings in 1996.
Except for Mssrs. Fields and Lipper, each member of the Board of
Directors who is not an officer or employee of the Company receives $8,000 per
year, plus $1,000 for each Board of Directors or committee meetings attended for
serving as Director. In 1996, Dr. Craigs Fields received an aggregate $ 24,000
from the Company, and Mr. Arther Lipper, and his affiliated entities, received
an aggregate of $ 50,000 from the Company. These sums include payments to Mssrs.
Fields and Lipper by the Company for various consulting services provided by
each of them to the Company in 1996, which services were in addition to their
duties as an outside director. The Company reimburses its Directors for
out-of-pocket expenses incurred in connection with meetings of the Board of
Directors or committee meetings attended. There are no family relationships
among any Directors or officers.
Compliance with Section 16(a) of the Exchange Act
Section 16(a) of the Securities Exchange Act of 1934 requires the
Company's officers and directors, and persons who own more than ten percent of
its Common Stock, to file reports of ownership and changes in ownership with the
Securities and Exchange Commission (the "Commission") and the National
Association of Securities Dealers, Inc. Officers, directors and
31
greater than ten percent stockholders are required by the Commission to furnish
the Company with copies of all Section 16(a) forms that they file.
Based solely on its review of the copies of such forms received by it,
or written representations from certain reporting persons that no reports on
Form 5 were required for those persons, the Company believes that during 1996
all filing requirements applicable to its officers, directors and greater than
ten percent stockholders were complied with.
32
Executive Compensation
The following table sets forth the cash compensation paid by the Company to
executive officers of the Company for the year ended December 31, 1996 whose
total annual salary and bonus exceeded $100,000:
SUMMARY COMPENSATION TABLE
Long Term Compensation
---------------------------------------------------------
Annual Compensation Awards Payouts
-------------------------------------------------------------------------------------------------------
(a) (b) (c) (d) (e) (f) (g) (h) (i)
Other Re- All
Annual stricted other
Compen- Stock LTIP Compen-
Name and sation Awards Options/ Payouts sation
Principal Position Year Salary($) Bonus($) $ $ SARs(#) $ $
- ------------------ ---- --------- -------- ------- ------- ------- ------- -------
Marvin Maslow,(1) 1996 $150,000 $ -0- $ -0- $ -0- 1,000,000(1) $ -0- $100,000(2)
Chief Executive 1995 $150,000 $ -0- $ -0- $ -0- -0- $ -0- $ -0-
Officer, Chairman 1994 $150,000 $ -0- $ -0- $ -0- 375,000 $ -0- $ -0-
of the Board of
Directors
Martin Holleran, 1996 $180,000 $ -0- $ -0- $ -0- 1,000,000(4) $ -0- $100,000(5)
President, Chief 1995 $180,000 $ -0- $ -0- $ -0- 50,000(3) $ -0- $ -0-
Operating Officer 1994 $180,000 $ -0- $ -0- $ -0-(3) 250,000 $ -0- $ -0-
and Director
Sherman Langer 1996 $130,000 $30,000 $ -0- $ -0- 100,000 $ -0- $ -0-
Senior Vice
President of
Marketing and
Sales and Director
33
- ------------------
(1) On March 12, 1996, the Company cancelled 187,500 unvested stock options
granted in 1994 having an exercise price of $5.375 per share and granted
Mr. Maslow 1,000,000 non-qualified stock options having an exercise price
of $4.375 per share, which exercise price was subsequently reduced to $3.00
on January 9, 1997. To date, 333,333 of these options have vested, and the
balance vest upon the Company achieving certain milestones.
(2) Represents a one-time cost-of-living adjustment made to Mr. Maslow's July
1990 employment agreement with the Company. Mr. Maslow also has (i) a
$2,000 per month non-accountable expense allowance for business and
entertaining; and (ii) a car allowance with respect to monthly lease and
garage payments for one (1) automobile. In addition, in accordance with Mr.
Maslow's new executive employment agreement entered into with the Company
as of March 1, 1997, Mr. Maslow is entitled to other expense
reimbursements. Also pursuant to Mr. Maslow's new employment agreement, the
Company has agreed to maintain, at its expense, a $1,000,000 life insurance
policy on Mr. Maslow's life for the benefit of his wife.
(3) Mr. Holleran had a restricted stock award of 50,000 shares of common stock
pursuant to his Employment Agreement with the Company dated November 1,
1993. The vesting schedule relative to all 50,000 shares of restricted
common stock was amended by the Board of Directors on October 21, 1994.
Fifty percent (50%) of such 50,000 shares previously vested in annual
increments of 1/3 each commencing November 1, 1994, and the other fifty
percent (50%) of such shares vested in annual increments of 1/3 each,
commencing November 1, 1994, provided that certain performance criteria
were met. All such 50,000 shares vested on January 1, 1995. In December
1995, Mr. Holleran's Employment Agreement with the Company was amended to
cancel the restricted stock award and replace it with 50,000 non-qualified
stock options exercisable at the then current market price of $4.375 per
share.
(4) On March 12, 1996, the Company cancelled 125,000 unvested stock options
granted in 1994 having an exercise price of $5.375 per share and granted
Mr. Holleran 1,000,000 non-qualified stock options having an exercise
price of $4.375 per share, which exercise price was subsequently reduced to
$3.00 on January 9, 1997. To date, 333,333 of these options have vested,
and the balance vest upon the Company achieving certain milestones.
34
(5) Represents a one-time cost-of-living adjustment made to Mr. Holleran's 1993
employment agreement with the Company. In addition, in accordance with Mr.
Holleran's new executive employment agreement entered into with the Company
as of March 1, 1997, Mr. Holleran is entitled to other expense
reimbursements. Also pursuant to his new employment agreement, the Company
has agreed with Mr. Holleran to maintain, at its expense, a $1,000,000 life
insurance policy on Mr. Holleran's life, for the benefit of his wife.
35
AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR
AND FISCAL YEAR END OPTION/SAR VALUES
(a) (b) (c) (d) (e)
Value of
Number of Unexercised
Unexercised In-the-Money
Options/SARs Options/SARs
at Fiscal at Fiscal
Year End (#) Year End ($)
Shares
Name and Acquired on Value Exercisable/ Exercisable/
Principal Position Exercise (#) Realized ($) Unexercisable Unexercisable
- ------------------- ------------ ------------ ------------- -------------
Marvin Maslow -0- N/A 708,333 Exercisable/ 0/0
Chief Executive 666,664 Unexercisable
Officer, Chairman
of the Board of
Directors
Martin Holleran, -0- N/A 583,333 Exercisable/ 0/0
President and Chief 666,664 Unexercisable
Operating Officer
Martin Fife, -0- N/A 100,000 Exercisable/ 0/0
Vice Chairman of the 50,000 Unexercisable
Board of Directors
Jules Zimmerman, -0- N/A 70,000 Exercisable/ 0/0
Chief Financial 50,000 Unexercisable
Officer and Director
36
AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR
AND FISCAL YEAR END OPTION/SAR VALUES
(a) (b) (c) (d) (e)
Value of
Number of Unexercised
Unexercised In-the-Money
Options/SARs Options/SARs
at Fiscal at Fiscal
Year End (#) Year End ($)
Shares
Name and Acquired on Value Exercisable/ Exercisable/
Principal Position Exercise (#) Realized ($) Unexercisable Unexercisable
- ------------------- ------------ ------------ ------------- -------------
(cont'd)
Sherman Langer, -0- N/A 152,000 Exercisable $7,875/0
Senior Vice President
of Marketing and
Sales and Director
Craig Fields, -0- N/A 83,332 Exercisable/ 0/0
Director 66,668 Unexercisable
Richard Hickok, -0- N/A 50,000 Exercisable/ 0/0
Director 50,000 Unexercisable
Arthur Lipper III -0- N/A 0 Exercisable/ 0/0
Director 0 Unexercisable
37
Executive Employment Agreements
The Company entered into an employment agreement in July 1990 with Marvin
Maslow to serve as Chief Executive Officer of the Company. Mr. Maslow's
employment agreement, which was to initially expire in July, 1995, was
automatically extended in January 1995 by its terms for an additional 30 months.
That employment agreement was terminated and replaced with a new executive
employment agreement effective March 1, 1997. Under the terms of his new
employment agreement, Mr. Maslow receives the same salary and benefits that he
received under his old employment agreement which were a salary of $150,000 per
year, a $2,000 per month non-accountable expenses allowance, and a car
allowance. In addition, pursuant to his new employment agreement, Mr. Maslow is
entitled to other expense reimbursements. Finally, the Company is providing a
$1,000,000 life insurance policy on Mr. Maslow's life for the benefit of his
wife. Mr. Maslow is required to devote substantially all of his time to the
business of the Company. The term of Mr. Maslow's new employment agreement is
six (6) years with a two-year extension, and it contains change in control
provisions. The Company provides for a $ 500,000 life insurance policy for the
benefit of the Company.
The Company entered into a three (3) year employment agreement with Mr.
Martin Holleran in November 1993 to serve as the Company's President and Chief
Operating Officer at a salary of $180,000 per year. Upon the expiration of this
agreement (which was orally extended by the parties subsequent to its term), the
Company entered into a new executive employment agreement with Mr. Holleran
effective March 1, 1997. Under his new executive employment agreement, Mr.
Holleran receives a salary of $220,000 per year and is required to devote all of
his time to the business of the Company. Mr. Holleran also is entitled to other
expense reimbursements. In addition, the Company provides to Mr. Holleran a
$1,000,000 life insurance policy for the benefit of his wife. The term of Mr.
Holleran's new executive employment agreement is six (6) years with a two-year
extension, and it contains change in control provisions. The Company provides
for a $ 1,000,000 life insurance policy for the benefit of the Company.
Effective January 1, 1997, the Company entered into an executive employment
agreement with Mr. Sherman Langer. The term of Mr. Langer's employment agreement
is three (3) years and provides for a salary of $165,000 per year and also
contains certain change in control provisions.
Each of Messrs. Maslow, Holleran and Langer have agreed not to compete
with the Company during the term of his respective
38
employment agreement or for a period of two years after the termination thereof.
All of the executive employment agreements contain termination for cause
provisions.
Subsequent to the closing of the Company's initial public offering in 1990,
the Company retained Jules Zimmerman as Chief Financial Officer of the Company.
In connection therewith, the Company entered into a consulting agreement with
Mr. Zimmerman and Hickok Associates whereby the Company is billed on an hourly
basis for the work performed by Mr. Zimmerman. Hickok Associates discontinued
operations as of December 31, 1996. Since that time Mr. Zimmerman has continued
to provide his services to the Company as Chief Financial Officer on an hourly
basis.
Indemnification Agreements
The Company has entered into an Indemnification Agreement with each of its
Directors and any officer, employee, agent or fiduciary designated by the Board
of Directors which provides that the Company indemnify the Director or other
party thereto to the fullest extent permitted by applicable law. The agreement
includes indemnification, to the extent permitted by applicable law, against
expenses, including reasonable attorneys' fees, judgments, penalties, fines and
amounts paid in settlement actually and reasonably incurred by him in connection
with any civil or criminal action or administrative proceeding arising out of
the indemnitee's performance of his duties as a Director or officer of the
Company. Such indemnification is available if the indemnitee acted in good faith
and in a manner he reasonably believed to be in, or not opposed to, the best
interests of the Company, and, with respect to any criminal action, had no
reasonable cause to believe his conduct was unlawful.
Under the Indemnification Agreement, the entitlement of a Director or
officer to indemnification will be determined by a majority vote of a quorum of
disinterested Directors, or if such quorum either is not obtainable or so
directs, by independent counsel or by the stockholders of the Company, as
determined by such disinterested Directors. If a change of control of the
Company has occurred, the entitlement of such Director or officer to
indemnification shall be determined by independent counsel selected by such
Director or officer, unless such Director or officer requests that either the
Board or the stockholders make such determination.
Each Indemnification Agreement will require the Company to advance
litigation expenses at the request of the Director or officer who is a party
thereto whether prior to or after final resolution of a proceeding, provided
that he undertakes to repay such advances if it is ultimately determined that he
is not
39
entitled to indemnification for his expense. The advance of litigation expenses
will thereby be mandatory upon satisfaction of certain conditions by such
Director or officer.
The Company has entered into an Indemnification Agreement with all of its
Directors and officers. In addition, upon Dr. Fields' joining the Company's
Board of Directors, the Company also agreed to indemnify Dr. Fields with respect
to the aforementioned litigation relating to Tamarack during the period prior to
Dr. Fields' joining the Company's Board of Directors. The Company has obtained
officers' and directors' liability insurance which provides a maximum of
$4,000,000 of coverage, subject to a $100,000 deductible payable by the Company
except under certain circumstances for securities related matters in which case
the deductible is $200,000. Any payments made by the Company under an
Indemnification Agreement which are not covered by the insurance policy may have
an adverse impact on the Company's earnings.
Stock Option Plans and Agreements
Incentive Option Plan - In February 1990, the Directors of the Company
adopted and the stockholders of the Company approved the adoption of the
Company's 1990 Incentive Stock Option and Appreciation Plan which was amended in
June and July 1990. The purpose of the Incentive Option Plan is to enable the
Company to encourage key employees and Directors to contribute to the success of
the Company by granting such employees and Directors incentive stock options
("ISOs"), as well as non-qualified options and options and stock appreciation
rights ("SARs"). In November of 1993, a majority of the stockholders of the
issued and outstanding shares of common stock voted in favor of increasing the
number of shares with respect to which options and SARs may be granted under the
Incentive Option Plan from 400,000 to 1,000,000.
The Incentive Option Plan will be administered by the Board of Directors
which will determine, in its discretion, among other things, the recipients of
grants, whether a grant will consist of ISOs, non-qualified options or SARs (in
tandem with an option or freestanding) or a combination thereof, and the number
of shares to be subject to such options and SARs.
The Incentive Option Plan provides for the granting of ISOs to purchase
Common Stock at an exercise price not less than the fair market value of the
Common Stock on the date the option is granted. Non-qualified options and
freestanding SARs may be granted with any exercise price. SARs granted in tandem
with an option have the same exercise price as the related option.
40
The total number of shares with respect to which options and SARs may be
granted under the Incentive Option Plan is 1,000,000. ISOs may not be granted to
an individual to the extent that in the calendar year in which such ISOs first
become exercisable the shares subject to such ISOs have a fair market value on
the date of grant in excess of $100,000. No option or SAR may be granted under
the incentive Option Plan after February 20, 2000 and no option or SAR may be
outstanding for more than ten years after its grant.
Upon the exercise of an option, the holder must make payment of the full
exercise price. Such payment may be made in cash or in shares of Common Stock
(based on the fair market value of the Common Stock on the date prior to
exercise), or in a combination of both. The Company may lend to the holder of an
option funds sufficient to pay the exercise price, subject to certain
limitations. SARs may be settled, in the Board of Directors' discretion, in
cash, Common Stock, or in a combination of cash and Stock. The exercise of SARs
cancels the corresponding number of shares subject to the related option, if
any, and the exercise of an option cancels any associated SARs. Subject to
certain exceptions, options and SARs may be exercised any time up to three
months after termination of the holder's employment.
The Incentive Option Plan may be terminated or amended at any time by the
Board of Directors, except that, without stockholder approval, the Incentive
Option Plan may not be amended to increase the number of shares subject to the
Incentive Option Plan, change the class of persons eligible to receive options
or SARs under the Incentive Option Plan or materially increase the benefits of
participants.
To date no options or SARs have been granted under the Incentive Option
Plan. No determinations have been made regarding the persons to whom options or
SARs will be granted in the future, the number of shares which will be subject
to such options or SARs or the exercise prices to be fixed with respect to any
option or SAR.
Non-Qualified Option Plan - In February 1990, the Directors and
stockholders of the Company adopted the 1990 Non-Qualified Stock Option Plan
which was amended in June and July 1990. The purpose of the Non-Qualified Option
Plan is to enable the Company to encourage key employees, Directors and
consultants to contribute to the success of the Company by granting such
employees, Directors and consultants non-qualified options. The Non-Qualified
Option Plan will be administered by the Board of Directors in the same manner as
the Incentive Option Plan.
41
The Non-Qualified Option Plan provides for the granting of non-qualified
options at such exercise price as may be determined by the Board of Directors,
in its discretion. In November of 1993, a majority of the stockholders of the
issued and outstanding shares of common stock voted in favor of increasing the
number of shares with respect to which options and SARs may be granted under the
Incentive Option Plan from 400,000 to 1,000,000 and with respect to which
options may be granted under the Non-Qualified Plan from 1,500,000 to 5,000,000.
Upon the exercise of an option, the holder must make payment of the full
exercise price. Such payment may be made in cash or in shares of Common Stock
(based on the fair market value of the Common Stock on the date prior to
exercise), or in a combination of both. The Company may lend to the holder of an
option funds sufficient to pay the exercise price, subject to certain
limitations. Subject to certain exceptions, options may be exercised any time up
to three months after termination of the holder's employment.
The Non-Qualified Option Plan may be terminated or amended at any time by
the Board of Directors, except that, without stockholder approval, the
Non-Qualified Option Plan may not be amended to increase the number of shares
subject to the Non- Qualified Option Plan, change the class of persons eligible
to receive options under the Non-Qualified Option Plan or materially increase
the benefits of participants.
As of December 31, 1996, an aggregate of 4,208,833 options have been
granted under the Non-Qualified Option Plan. As of December 31, 1996, 230,000
non-qualified options have been exercised.
42
Performance Graph
Co. Index Mkt Index Peer Index
--------- --------- ----------
12/31/91 100 100 100
1/31/92 315.789 105.847 110.797
2/28/92 463.158 108.246 112.452
3/31/92 442.105 103.137 102.591
4/30/92 531.579 98.714 95.875
5/29/92 500 99.996 96.288
6/30/92 352.632 96.086 87.842
7/31/92 484.21 99.49 89.165
8/31/92 400 96.449 83.648
9/30/92 336.842 100.034 88.913
10/30/92 463.158 103.974 99.325
11/30/92 431.579 112.247 115.566
12/31/92 463.158 116.378 119.135
1/29/93 452.632 119.691 131.25
2/26/93 736.842 115.226 125.477
3/31/93 1368.421 118.561 131.657
4/30/93 1157.895 113.501 132.77
5/28/93 1052.632 120.281 147.855
6/30/93 789.474 120.837 158.697
7/30/93 800 120.98 166.94
8/31/93 1063.158 127.233 183.851
9/30/93 897.684 131.022 191.618
10/29/93 1007.158 133.967 200.838
11/30/93 842.948 129.972 181.595
12/31/93 963.369 133.595 194.197
1/31/94 777.263 137.65 195.744
2/28/94 602.105 136.363 190.491
3/31/94 591.158 127.976 178.455
4/29/94 591.158 126.315 184.845
5/31/94 437.895 126.624 165.529
6/30/94 536.421 121.993 155.051
7/29/94 459.79 124.495 163.363
8/31/94 481.685 132.432 182.064
9/30/94 448.842 132.093 181.168
10/31/94 503.579 134.689 204.654
11/30/94 437.895 130.221 203.625
12/30/94 377.684 130.586 220.306
1/31/95 306.526 131.318 213.617
2/28/95 284.632 138.263 229.394
3/31/95 295.579 142.361 240.693
4/28/95 224.421 146.843 254.764
5/31/95 208 150.63 258.144
6/30/95 273.684 162.836 305.694
7/31/95 262.737 174.805 341.561
8/31/95 290.105 178.348 344.642
9/29/95 410.526 182.449 365.042
10/31/95 492.632 181.404 336.587
11/30/95 328.421 185.663 362.05
12/29/95 416 184.675 341.779
1/31/96 394.105 185.588 333.859
2/29/96 416 192.66 356.716
3/29/96 355.789 193.301 351.869
4/30/96 197.053 209.34 418.953
5/31/96 251.789 218.952 472.652
6/28/96 317.474 209.081 454.682
7/31/96 257.263 190.458 366.644
8/30/96 339.368 201.129 393.857
9/30/96 350.316 216.523 414.888
10/31/96 328.421 214.128 391.279
11/29/96 295.579 227.378 405.202
12/31/96 224.421 227.142 378.783
43
Item 12. SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information, as of March 13, 1997,
known to the Company regarding beneficial ownership of the Company's Common
Stock by: (i) any holder of more than five percent of the outstanding shares;
(ii) the Company's directors; and (iii) the directors and officers of the
Company as a group:
Shares Percentage Shares Percentage
of (%) of of (%) of
Common Total Preferred Total
Stock Common Stock Preferred
Name Owned(1)(2) Stock(3) Owned Stock
- ---- ----------- ---------- --------- ----------
Martin D. Fife (4) 261,668 1.6% - 0 - - 0 -
405 Lexington Avenue
New York, NY 10174
Richard S. Hickok (5) 105,000 .6% - 0 - - 0 -
11 Deep Pond Circle
South Orleans, MA 02662
Marvin Maslow (6) 1,398,323 8.5% 25,000 7.1%
Projectavision, Inc.
Two Penn Plaza
Suite 640
New York, NY 10121
Jules Zimmerman (7) 120,000 .7% - 0 - - 0 -
20 West 64th Street
New York, NY 10023
Martin Holleran (8) 1,300,000 7.9% - 0 - - 0 -
Projectavision, Inc.
Two Penn Plaza
Suite 640
New York, NY 10121
Dr. Craig I. Fields (9) 150,000 .9% - 0 - - 0 -
1101 30th Street, N.W.
Suite 500
Washington, D.C. 20007
44
Shares Percentage Shares Percentage
of (%) of of (%) of
Common Total Preferred Total
Stock Common Stock Preferred
Name Owned(1)(2) Stock(3) Owned Stock
- ---- ----------- ---------- --------- ----------
Sherman Langer (10) 152,000 .9% - 0 - - 0 -
Projectavision, Inc.
Two Penn Plaza
Suite 640
New York, NY 10121
Arthur Lipper, III -0- -0- - 0 - - 0 -
14911 Carninito Ledera
Del Mar, CA 92014
All Directors, Nominees
and Officers Group
(consisting of
7 persons)(4)(5)(6)(7)
(8)(9)(10) 3,486,991 17.6% 25,000 7.1%
- ------------------
(1) Except as otherwise indicated, all shares of Common Stock are beneficially
owned, and sole investment and voting power is held, by the persons named.
(2) Gives effect to the reverse stock split of one-for- 11.3467611 shares of
Common Stock in February, 1990, two-for-three shares of Common Stock in
July, 1990, and two-for-one stock split in March, 1992.
(3) Outstanding Common Stock does not include any shares of Common Stock
issuable upon the exercise of any outstanding options or warrants.
(4) Includes 150,000 non-qualified options granted to and beneficially owned by
Mr. Fife to acquire 150,000 shares of Common Stock. Does not include
(i) 100 shares of non-voting Series A Preferred Stock issued to Mr. Fife in
connection with the Merger.
(5) Includes 100,000 non-qualified options granted to and beneficially owned by
Mr. Hickok to acquire an aggregate of 100,000 shares of Common Stock of the
Company.
(6) Includes (i) 1,375,000 shares of Common Stock subject to 1,375,000
non-qualified stock options. Does not include 4,038 shares of Common Stock
owned by Mr. Maslow's adult child. Mr. Maslow disclaims beneficial
ownership of the shares of Common Stock owned by his adult child. Mr.
Maslow received 25,000 shares of Series B Preferred Stock on May 15, 1992
for services rendered in the second quarter of 1992. Mr. Maslow has agreed
with the Company that he shall not sell any of the shares of Series B
Preferred Stock until the earlier of (i) the Company having entered into a
definitive revenue generating agreement with a major manufacturer, licensor
or distributor with respect to the licensing of the company's technology,
or (ii) the company
45
has effected an acquisition of another company, license or technology that
will result in the immediate realization of revenues on the Company's
behalf. In the event that neither (i) or (ii) shall have occurred on or
before May 15, 1997, Mr. Maslow has agreed to return all of their shares of
Series B Preferred Stock to the Company.
(7) Includes 120,000 non-qualified options granted to and beneficially owned by
Mr. Zimmerman to acquire 120,000 shares of the Company's Common Stock.
(8) Includes 1,250,000 non-qualified options granted to and beneficially owned
by Mr. Holleran to acquire 1,250,000 shares of the Company's Common Stock.
(9) Includes 150,000 non-qualified options granted to and beneficially owned by
Dr. Fields to acquire 150,000 shares of the Company's Common Stock.
(10) Includes 152,000 non-qualified options granted to and beneficially owned by
Mr. Langer to acquire 152,000 shares of the Company's Common Stock.
46
Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Through July 31, 1995 the Company made advances of approximately $218,000
to another entity, whose president is the brother of Martin Holleran, the
Company's President and Chief Operating Officer, in contemplation of making an
investment in such other entity. The Company ultimately did not make such an
investment and the advance was fully reserved for on the Company's financial
statements as of December 31, 1995. In November, 1996, $109,166 of the advance
was repaid to the Company as a final settlement of amounts advanced.
47
PART IV
Item 14. EXHIBITS, FINANCIAL STATEMENT
SCHEDULES AND REPORTS ON FORM 8-K
(a) (1) Financial Statements
The following financial statements of the Company are incorporated herein
by reference to Part II, Item 8:
Independent Auditors' Report F - 1
Balance Sheets at December 31, 1995 and 1996 F - 2
Statements of Operations for the Years Ended
December 31, 1994, December 31, 1995 and
December 31, 1996 and the Period
September 9, 1988 (Date of Incorporation)
to December 31, 1996 F - 3
Statements of Stockholders' Equity F - 4
Statements of Cash Flows for the Years Ended
December 31, 1994, December 31, 1995 and
December 31, 1996 and for the Period
September 9, 1988 (Date of Incorporation)
to December 31, 1996 F - 6
Notes to Financial Statements F - 8
(a) (2) Financial Statement Schedules
All schedules are omitted because they are not applicable or the
information required is included in the financial statements and notes thereto.
(a) (3) Exhibits
The following is a list of exhibits filed as part of the Annual Report on
Form 10-K for the fiscal year ended December 31, 1996.
Exhibit No.
3.2.1 Certificate of Designation of Convertible Series C
Preferred Stock
3.2.2 Certificate of Designation of Convertible Series D
Preferred Stock
48
10.50 Executive Employment Agreement of Martin Holleran dated
March 1, 1997
10.51 Executive Employment Agreement of Marvin Maslow dated
March 1, 1997
27 Financial Data Schedule
49
INDEPENDENT AUDITORS' REPORT
To the Board of Directors of Projectavision, Inc.:
We have audited the accompanying balance sheets of Projectavision, Inc. (a
development stage company) (the "Company") as of December 31, 1995 and 1996, and
the related statements of operations, stockholders' equity and cash flows for
each of the three years in the period ended December 31, 1996, and for the
period September 9, 1988 (date of incorporation) to December 31, 1996. These
financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits and the report of the other auditors
provide a reasonable basis for our opinion.
In our opinion, such financial statements present fairly, in all material
respects, the financial position of Projectavision, Inc. as of December 31, 1995
and 1996 and the results of its operations and its cash flows for each of the
three years in the period ended December 31, 1996 and for the period September
9, 1988 (date of incorporation) to December 31, 1996 in conformity with
generally accepted accounting principles.
As discussed in Note 14 to the financial statements, the Company is a defendant
in several lawsuits alleging, among other complaints, breaches of employment,
patent assignment agreements and wrongful termination, claiming actual and
punitive damages.
The Company is in the development stage as of December 31, 1996. As discussed in
Note 1 to the financial statements, successful completion of the Company's
development program and, ultimately, the attainment of profitable operations is
dependent upon future events, including maintaining adequate financing to
fulfill its development activities and achieving a level of revenue adequate to
support the Company's cost structure.
/s/ Deloitte & Touche LLP
- --------------------------------------
New York, New York
March 25, 1997
PROJECTAVISION, INC
(A Development Stage Company)
BALANCE SHEETS
- -------------------------------------------------------------------------------
December 31,
-----------------------------------
ASSETS 1995 1996
CURRENT ASSETS:
Cash and cash equivalents $3,491,982 $ 1,060,283
Investments - 3,437,386
Other current assets 335,153 851,198
---------- --------------
Total Current Assets 3,827,135 5,348,867
PROPERTY AND EQUIPMENT
Furniture, fixtures and equipment 68,422 68,422
Tooling Costs 0 4,208,005
Computers and software 116,155 226,019
Leasehold improvements 180,795 185,030
---------- --------------
365,371 4,687,476
Less: Accumulated depreciation 151,612 242,896
---------- --------------
Property and equipment, net 213,759 4,444,580
OTHER ASSETS 127,521 339,041
---------- --------------
TOTAL ASSETS $4,168,415 $10,132,488
========== ==============
LIABILITIES AND STOCKHOLDERS' EOUITY
CURRENT LIABILITIES:
Accounts payable and accrued expenses $ 485,710 $ 1,927,480
---------- --------------
Total Current Liabilities 485,710 1,927,480
---------- --------------
LONG-TERM CONVERTIBLE DEBT - NET - 1,762,963
COMMITMENTS AND CONTINGENCIES - -
STOCKHOLDERS' EQUITY
Preferred stocks
Series A Preferred Stock, $.01 par value
1,000,000 shares authorized, 100 shares issued
($100,000 liquidation preference) - -
Series B Preferred Stock, $.01 par value
1,000,000 shares authorized, 385,982 shares outstanding
($ 1,929,910 liquidation preference) 3,859 3,859
Series C Preferred Stock, $.001 par value
1,000,000 shares authorized; 7,500 shares issued;
($100,000 liquidation preference) - 8
Common stock $.0001 par value - 30,000,000 shares
authorized; 12,388,790 and 14,229,401 issued and
outstanding in 1995 and 1996 respectively 1,239 1,423
Additional paid-in capital 24,318,651 38,760,690
Deficit accumulated during the development stage (20,641,044) (32,323,935)
---------- --------------
Total Stockholders' Equity 3,682,705 6,442,045
---------- --------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $4,168,415 $ 10,132,488
========== =============
F-2
See notes to financial statements
PROJECTAVISION, INC
(A Development Stage Company)
STATEMENTS OF OPERATIONS
- ------------------------------------------------------------------------------
For the Period
September 9,
1988 (Date of
Years Ended December 31, incorporation)
---------------------------------------------------- to December 31,
1994 1995 1996 1996
REVENUE $ - $ 200,000 $ 150,000 $ 1,455,000
------------ ----------- ---------- -----------
OPERATING EXPENSES
General and administrative 2,132,222 1,562,746 2,179,132 9,368,762
Salaries 804,111 778,279 1,266,287 4,825,856
Legal fees 152,000 1,001,737 1,017,909 3,038,058
Depreciation 62,050 73,739 91,284 298,334
Research and development 827,660 608,651 2,389,329 5,811,252
Patent and license expense 122,280 243,229 362,967 1,488,052
------------ ----------- ---------- -----------
Total Operating Expenses 4,100,323 4,268,381 7,306,908 24,830,314
------------ ----------- ---------- -----------
LOSS FROM OPERATIONS (4,100,323) (4,068,381) (7,156,908) (23,375,314)
------------ ----------- ---------- -----------
OTHER INCOME (EXPENSE)
(Provision for)/recovery of
allowances on advances (173,409) (125,017) 109,166 (189,260)
Interest income 333,146 362,107 458,979 1,506,860
Interest expense (352,049) (378,719)
Interest expense - Amortization of debt expense - - (2,034,683) (2,034,683)
------------ ----------- ---------- -----------
Other income/(expense) - Net 159,737 237,090 (1,818,587) (1,095,802)
------------ ----------- ---------- -----------
LOSS BEFORE EQUITY IN LOSS OF
UNCONSOLIDATED AFFILIATE (3,940,586) (3,831,291) (8,985,495) (24,471,116)
------------ ----------- ---------- -----------
EQUITY IN LOSS OF
UNCONSOLIDATED AFFILIATE (1,691,697) (2,640,347) (72,065) (4,897,314)
------------ ----------- ---------- -----------
NET LOSS $ (5,632,282) $(6,471,638) $(9,047,560) $(29,368,430)
============ =========== ========== ===========
NET LOSS PER SHARE $( .47) $( .51) $( .86)
============ =========== ==========
AVERAGE NUMBER OF SHARES
OUTSTANDING 11,679,932 12,390,962 13,586,705
============ =========== ==========
F-3
See Notes to Financial Statements
PROJECTAVISION, INC
(A Development Stage Company)
STATEMENTS OF STOCKHOLDERS' EQUITY
- ------------------------------------------------------------------------------
Series A Series B
Preferred Stock Preferred Stock Common Stock Proceeds Additional
------------------ -------------------- -------------------------------- Paid-in
Shares Amount Shares Amount Shares Per Share Amount Capital
ISSUANCE OF COMMON STOCK
TO FOUNDERS FOR CASH 3,849,544 $.00002 $ 106 $
ISSUANCE OF COMMON STOCK
TO INVESTORS FOR CASH 98,706 1.01 289 99,711
MERGER WITH DKY, INC.
Issuance of preferred stock 100 NL (300,000)
Distribution to DKY
stockholders 100,900
NET LOSS
------ ----- --------- ------- -----------
BALANCE, DECEMBER 31, 1988 100 NL 3,948,250 1.32 395 (99,389)
ISSUANCE OF COMMON STOCK
TO INVESTORS FOR CASH
(Net of private placement
costs) 518,416 1.32 52 681,443
NET LOSS
------ ----- --------- ------- -----------
BALANCE, DECEMBER 31, 1989 100 NL 4,466,666 447 582,054
REVERSAL OF ACCRUAL FOR
PRIVATE PLACEMENT COSTS 50,000
INITIAL PUBLIC OFFERING
(Net of Public offering
costs) 1,600,000 1.86 160 2,977,472
NET LOSS
------ ----- --------- ------- -----------
BALANCE, DECEMBER 31, 1990 100 NL 6,066,666 607 3,609,526
ISSUANCE OF COMMON STOCK
FOR SERVICES 281,251 .83-1.24 27 311,223
NET LOSS
------ ----- --------- ------- -----------
BALANCE, DECEMBER 31, 1991 100 NL 6,347,917 635 3,920,749
ISSUANCE OF COMMON
STOCK FOR CONSULTING FEES 200,000 1.4 20 287,481
ISSUANCE OF COMMON
STOCK FOR CASH 463,793 2.14-2.70 47 1,295,053
ISSUANCE OF SERIES B
PREFERRED STOCK FOR
SALARIES 80,000 $ 800 359,200
ISSUANCE OF SERIES B
PREFERRED STOCK FOR
SERVICES 88,000 880 395,120
ISSUANCE OF COMMON STOCK FOR
CASH INCLUDING 28,064
SHARES ISSUED FOR
COMMISSION 391,700 2.55 39 999,961
ISSUANCE OF COMMON STOCK
FOR WARRANTS AND CASH 500,000 50 499,950
ISSUANCE OF COMMON AND
PREFERRED STOCK FOR
WARRANTS 246,452 2,464 1,483,200 148 2,222,188
ISSUANCE OF COMMON STOCK
FOR PATENT COSTS 37,065 3 37,062
AMORTIZATION OF UNEARNED
COMPENSATION
NET LOSS
------ ----- ------- ------ --------- ------ -----------
BALANCE, DECEMBER 31, 1992 100 NL 414,452 4,144 9,423,675 942 10,016,764
ISSUANCE OF COMMON STOCK
FOR BONUS 2,000 3.41 6,825
ISSUANCE OF COMMON STOCK
FOR SERVICES 109,500 3.41 11 373,658
ISSUANCE OF COMMON STOCK
FOR STOCK OPTIONS
EXERCISED 230,000 23 332,977
ISSUANCE OF COMMON STOCK
FOR CASH 880,230 89 5,363,995
ISSUANCE OF COMMON STOCK
FOR WARRANTS 18,743 1 33,411
AMORTIZATION OF UNEARNED
COMPENSATION
NET LOSS
------ ----- ------- ------ --------- ------ -----------
BALANCE, DECEMBER 31, 1993 100 $NL 414,452 $4,144 10,664,148 $1,066 $16,127,630
------ ----- ------- ------ --------- ------ -----------
[RESTUBED TABLE]
Deficit Accumulated
During the
Development Unearned
Stage Compensation Total
ISSUANCE OF COMMON STOCK
TO FOUNDERS FOR CASH $ $ $ 106
ISSUANCE OF COMMON STOCK
TO INVESTORS FOR CASH 100,000
MERGER WITH DKY, INC.
Issuance of preferred stock (300,000)
Distribution to DKY
stockholders 100,900
NET LOSS (257,443) (257,443)
----------- ----------- ---------
BALANCE, DECEMBER 31, 1988 (257,443) 0 (356,437)
ISSUANCE OF COMMON STOCK
TO INVESTORS FOR CASH
(Net of private placement
costs) 681,495
NET LOSS (589,653) (589,653)
----------- ----------- ---------
BALANCE, DECEMBER 31, 1989 (847,096) 0 (264,595)
REVERSAL OF ACCRUAL FOR
PRIVATE PLACEMENT COSTS 50,000
INITIAL PUBLIC OFFERING
(Net of Public offering
costs) 2,977,632
NET LOSS (1,019,315) (1,019,315)
----------- ----------- ---------
BALANCE, DECEMBER 31, 1990 (1,866,411) 0 1,743,722
ISSUANCE OF COMMON STOCK
FOR SERVICES 311,251
NET LOSS (1,617,501) (1,617,501)
----------- ----------- ---------
BALANCE, DECEMBER 31, 1991 (3,483,912) 0 437,472
ISSUANCE OF COMMON
STOCK FOR CONSULTING FEES (287,501) 0
ISSUANCE OF COMMON
STOCK FOR CASH 1,295,100
ISSUANCE OF SERIES B
PREFERRED STOCK FOR
SALARIES 360,000
ISSUANCE OF SERIES B
PREFERRED STOCK FOR
SERVICES (49,659) 346,341
ISSUANCE OF COMMON STOCK FOR
CASH INCLUDING 28,064
SHARES ISSUED FOR
COMMISSION 1,000,000
ISSUANCE OF COMMON STOCK
FOR WARRANTS AND CASH 500,000
ISSUANCE OF COMMON AND
PREFERRED STOCK FOR
WARRANTS 2,224,800
ISSUANCE OF COMMON STOCK
FOR PATENT COSTS 37,065
AMORTIZATION OF UNEARNED
COMPENSATION 147,771 147,771
NET LOSS (2,002,795) (2,002,795)
----------- ----------- ---------
BALANCE, DECEMBER 31, 1992 (5,486,707) (189,389) 4,345,754
ISSUANCE OF COMMON STOCK
FOR BONUS 6,825
ISSUANCE OF COMMON STOCK
FOR SERVICES 373,669
ISSUANCE OF COMMON STOCK
FOR STOCK OPTIONS
EXERCISED 333,000
ISSUANCE OF COMMON STOCK
FOR CASH 5,364,084
ISSUANCE OF COMMON STOCK
FOR WARRANTS 33,412
AMORTIZATION OF UNEARNED
COMPENSATION 183,419 183,419
NET LOSS (2,730,242) (2,730,242)
----------- ----------- ---------
BALANCE, DECEMBER 31, 1993 $(8,216,949) $ (5,970) $7,909,921
----------- ----------- ---------
F-4
See notes to financial statements
PROJECTAVISION, INC
(A Development Stage Company)
STATEMENTS OF STOCKHOLDERS' EQUITY
- ------------------------------------------------------------------------------
SERIES A SERIES B SERIES C
PREFERRED STOCK PREFERRED STOCK PREFERRED STOCK COMMON STOCK
SHARES AMOUNT SHARES AMOUNT SHARES AMOUNT SHARES AMOUNT
BALANCE, DECEMBER 31, 1993 100 NL 414,452 $4,144 0 NL 10,664,148 $1,066
ISSUANCE OF COMMON STOCK
FOR CASH 1,370,860 137
ISSUANCE OF COMMON STOCK
FOR SERVICES 52,500 5
EXERCISE OF STOCK OPTIONS 103,500 10
ISSUANCE OF COMMON STOCK
FOR BONUS 4,000 1
ISSUANCE OF COMMON STOCK
FOR PREFERRED STOCK
DIVIDENDS 27,887 3
EXERCISE OF STOCK WARRANTS 1,600 0
PREFERRED STOCK CONVERTED
TO COMMON STOCK (4,308) (43) 4,308 1
UNEARNED COMPENSATION
NET LOSS
----- ------ ------- ------ ------ ------ ---------- ------
BALANCE, DECEMBER 31, 1994 100 NL 410,144 4,101 0 NL 12,228,803 1,223
ISSUANCE OF COMMON STOCK
FOR PREFERRED STOCK
DIVIDENDS 52,795 6
ISSUANCE OF COMMON STOCK
FOR PREFERRED STOCK (24,162) (242) 24,162 2
ISSUANCE OF COMMON STOCK
FOR PROFESSIONAL SERVICES 83,030 8
NET LOSS
----- ------ ------- ------ ------ ------ ---------- ------
BALANCE, DECEMBER 31, 1995 100 NL 385,982 3,859 0 NL 12,388,790 1,239
ISSUANCE OF COMMON STOCK
FOR PREFERRED STOCK
DIVIDENDS 37,666 4
CONVERSION OF 8% DEBENTURES
INTO COMMON STOCK 1,772,945 177
ISSUANCE OF SERIES C
PREFERRED STOCK 7,500 8
SERIES C PREFERRED STOCK
PLACEMENT FEE
CASH DIVIDEND ON SERIES C
PREFERRED STOCK
EXERCISE OF STOCK OPTIONS 30,000 3
AMORTIZATION OF DISCOUNT ON
8% DEBENTURES
AMORTIZATION OF DISCOUNT
(DIVIDEND) ON SERIES C
PREFERRED STOCK
ISSUE WARRANTS AND OPTIONS
FOR SERVICES
NET LOSS
----- ------ ------- ------ ------ ------ ---------- ------
BALANCE, DECEMBER 31, 1996 100 NL 385,982 $3,859 7,500 $8 14,229,401 $1,423
===== ====== ======= ====== ====== ====== ========== ======
[RESTUBBED TABLE]
ACCUMULATED
ADDITIONAL DEFICIT DURING
PAID IN DEVELOPMENT
CAPITAL STAGE TOTAL
BALANCE, DECEMBER 31, 1993 $16,127,630 ($8,216,949) $7,909,921
ISSUANCE OF COMMON STOCK
FOR CASH 6,696,280 6,696,417
ISSUANCE OF COMMON STOCK
FOR SERVICES 229,245 229,250
EXERCISE OF STOCK OPTIONS 374,365 374,375
ISSUANCE OF COMMON STOCK
FOR BONUS 27,999 28,000
ISSUANCE OF COMMON STOCK
FOR PREFERRED STOCK
DIVIDENDS 165,778 (165,781) 0
EXERCISE OF STOCK WARRANTS 2,400 2,400
PREFERRED STOCK CONVERTED
TO COMMON STOCK 42 0
UNEARNED COMPENSATION 5,970
NET LOSS (5,632,283) (5,632,283)
---------- ----------- ----------
BALANCE, DECEMBER 31, 1994 23,623,739 (14,015,013) 9,614,050
ISSUANCE OF COMMON STOCK
FOR PREFERRED STOCK
DIVIDENDS 154,388 (154,393) NL
ISSUANCE OF COMMON STOCK
FOR PREFERRED STOCK 240
ISSUANCE OF COMMON STOCK
FOR PROFESSIONAL SERVICES 540,284 540,292
NET LOSS (6,471,638) (6,471,638)
---------- ----------- ----------
BALANCE, DECEMBER 31, 1995 24,318,651 (20,641,044) 3,682,705
ISSUANCE OF COMMON STOCK
FOR PREFERRED STOCK
DIVIDENDS 154,389 (154,393) 0
CONVERSION OF 8% DEBENTURES
INTO COMMON STOCK 3,441,573 3,441,750
ISSUANCE OF SERIES C
PREFERRED STOCK 7,499,992 7,500,000
SERIES C PREFERRED STOCK
PLACEMENT FEE (500,000) (500,000)
CASH DIVIDEND ON SERIES C
PREFERRED STOCK (123,750) (123,750)
EXERCISE OF STOCK OPTIONS 24,372 24,375
AMORTIZATION OF DISCOUNT ON
8% DEBENTURES 1,078,725 1,078,725
AMORTIZATION OF DISCOUNT
(DIVIDEND) ON SERIES C
PREFERRED STOCK 2,357,188 (2,357,188) 0
ISSUE WARRANTS AND OPTIONS
FOR SERVICES 385,800 385,800
NET LOSS (9,047,560) (9,047,560)
---------- ----------- ----------
BALANCE, DECEMBER 31, 1996 $38,760,690 ($32,323,935) $6,442,045
=========== =========== ==========
F-5
See notes to financial statements
PROJECTAVISION, INC
(A Development Stage Company)
STATEMENTS OF CASH FLOWS
- -------------------------------------------------------------------------------
For the Period
September 9,
1988 (Date of
Years Ended December 31, incorporation)
---------------------------------------------------- to December 31,
1994 1995 1996 1996
OPERATING ACTIVITIES
Net loss $ (5,632,283) $ (6,471,638) $ (9,047,560) $ (29,368,430)
Adjustments to reconcile net loss to net cash
used in operating activities:
Amortization and depreciation 62,050 73,739 2,215,967 2,333,019
Issuance of common stock for services 257,258 540,292 - 1,664,131
Other noncash operating expenses 5,970 - 5,970
Settlement of legal fees - - (97,287)
Provision for allowances on advances 173,409 125,017 (109,168) 189,260
Equity in loss of unconsolidated affiliate 1,691,697 511,094 72,065 2,768,061
Asset and liability management
Changes in operating assets (305,757) (179,370) (597,659) (1,534,050)
Accounts payable (131,410) 249,237 1,441,770 2,074,137
----------- ----------- ------------ ------------
Net cash used in operating activities (3,879,066) (5,151,629) (6,114,583) (21,608,592)
----------- ----------- ------------ ------------
INVESTING ACTIVITIES
Capital expenditures (288,312) (30,397) (4,322,105) (4,687,475)
Investment in and advances to unconsolidated
affiliate (1,500,000) (94,240) 0 (4,703,440)
Allowance taken on investment in unconsolidated
affiliate - 2,129,252 - 2,129,252
Interest accrued on loan to unconsolidated
affiliate (54,494) (67,314) - (121,808)
Licenses - - - (30,000)
(Purchase) and redemption of government
securities (2,993,320) 2,993,320 (3,437,386) (3,437,386)
----------- ----------- ------------ ------------
Net cash (used in)/provided by investing
activities (4,836,126) 4,930,621 (7,759,491) (10,850,857)
----------- ----------- ------------ ------------
FINANCING ACTIVITIES
Proceeds from notes payable - - 10,000,000 10,800,000
Private placement costs - - (500,000) (518,505)
Repayment of notes payable (22,705) - (4,958,250) (6,080,955)
Issuance of preferred stock - - 7,500,000 8,216,341
Issuance Fees - - (500,000) (500,000)
Series C Preferred Stock Dividend - - (123,750) (123,750)
Proceeds from Issuance of common stock 6,696,417 - - 18,617,239
Proceeds from warrants exercised 2,400 - - 2,760,612
Proceeds from stock options exercised 374,375 - 24,375 398,750
Deferred public offering costs - - - (50,000)
----------- ----------- ------------ ------------
Net cash provided by financing activities 7,050,487 0 11,442,375 33,519,732
----------- ----------- ------------ ------------
(DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS (1,664,705) (221,008) (2,431,699) 1,060,283
CASH AND CASH EQUIVALENTS-BEGINING OF PERIOD 5,377,695 3,712,990 3,491,982 -
CASH AND CASH EQUIVALENTS-END OF PERIOD $ 3,712,990 $ 3,491,982 $ 1,060,283 $ 1,060,283
=========== =========== ============= =============
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the period for interest $ 2,295 $ - $ 352,049 $ 354,344
=========== =========== ============= =============
F-6
See notes to financial statements
PROJECTAVISION, INC.
(A Development Stage Company)
SUPPLEMENTAL DISCLOSURE OF NONCASH
INVESTING AND FINANCING ACTIVITIES:
- ------------------------------------------------------------------------------
In 1994, the Company issued 1,500 shares of its common stock for services
rendered. In addition, the Company issued 27,887 shares of its common stock with
a value of $ 165,781 as payment for the dividend on its series B convertible
preferred stock, 4,000 shares of its common stock for bonuses, and 31,000 shares
of its common stock for services rendered in connection with its private
placements. Also, the Company issued 20,000 shares of its common stock for fees
regarding the exercise of the Company's stock warrants. Finally, the Company
issued 4,308 shares of its common stock for 4,308 shares of its series B
convertible preferred stock.
In 1995, the Company issued 52,782 of its common stock as payment with a value
of $ 154,393 for the dividend on its series B convertible preferred stock. In
addition, the Company issued 50,000 shares of its common stock for services
rendered by an officer and director of the Company. These shares were canceled
by the Company in December 1995. Also, the Company issued 24,162 shares of its
common stock for 24,162 shares of its series B convertible preferred stock, and
83,030 shares of its common stock for professional services rendered and to be
rendered.
In 1996, the Company issued 37,666 shares of its common stock with a value of
$154,393 as payment for the dividend on its series B convertible preferred
stock. Further, the Company recorded as a dividend on its Series C Convertible
Preferred Stock the amortization of discount of $2,357,188. In addition, the
Company issued 1,772,945 shares of its common stock and paid $4,958,250 in cash
in exchange for retiring $8.4 million of convertible debt.
F-7
PROJECTAVISION, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
- ------------------------------------------------------------------------------
1. ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES
Organization - Projectavision, Inc. (the "Company"), a Delaware
corporation, was incorporated on September 9, 1988. The Company has
been formed to complete development of a unique proprietary solid state
projection television and related video display technology. In
addition, the company will seek to identify new high technology and
electronic products for consumers and commercial customers. The Company
is a development stage enterprise and has generated no significant
revenue from its planned principal operations. Management of the
Company believes that it has sufficient funds to successfully complete
its development program and to sustain its operations. However, the
attainment of profitable operations is dependent upon future events
including achieving a level of revenue adequate to support the
Company's then cost structure.
Use of Estimates - The preparation of financial statements in
conformity with generally accepted accounting principles requires
management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.
Cash Equivalents - The company considers all highly liquid investments
with a maturity of three months or less when purchased to be cash
equivalents.
Property and Equipment - Property and equipment are stated at cost and
depreciated on the straight-line basis over the estimated useful lives
of the respective assets. Tooling costs for the Digital Home Theater
are being capitalized, with amortization to begin with production. The
estimated useful service lives of the assets are as follows:
Furniture, fixtures and equipment 7 years
Computers and software 5 years
Leasehold improvements 3 years
Investments - The Company places its temporary cash investments and
investments with high credit quality financial institutions and by
policy, limits the amount of credit exposure with any one financial
institution.
Research and Development - Costs are expensed as incurred.
Net Loss Per Share - Net loss per share is computed based on the number
of shares outstanding during the period and based on net loss after
extraordinary items after deducting dividends on preferred stock.
The effect of other potentially dilutive securities is not included
because their effect is anti-dilutive.
Income Taxes - The Company's accounting for income taxes is such that
deferred taxes, determined based on the difference between the
financial statement and tax basis of assets and liabilities, using
enacted tax rates, as well as any net operating or capital loss or tax
credit carry forwards are expected to reduce taxes payable in future
years.
Stock-Based Compensation - In October 1995, the FASB issued SFAS No.
123, "Accounting for Stock-Based Compensation," which requires adoption
of the disclosure provisions no later than fiscal years beginning after
December 15, 1995 and adoption of the measurement and recognition
provisions for non-employee transactions no later than after December
15, 1995. The standard defines a fair value method, compensation cost
is measured at the grant date based on the fair value of the award and
is recognized over the service period, which is usually the vesting
period. Pursuant to SFAS No. 123, companies are encouraged, but are not
required, to adopt the fair value method of accounting for employee
stock-based transactions. The Company will continue to account for such
transactions under Accounting Principles Board Opinion No. 25,
"Accounting for Stock Issued to Employees," but will disclose in a note
to the financial statements pro forma net income and per share amounts
as if the company had applied the new method of accounting.
F-8
PROJECTAVISION, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
- ------------------------------------------------------------------------------
2. REVENUE
Revenue for the period consisted of royalty income from licensing
agreements
Included in cumulative revenues is $ 1,000,000 in funding from a
government agency.
3. FAIR VALUE OF FINANCIAL INSTRUMENTS
At December 31, 1996, the fair values of cash, cash equivalents,
investments, and accounts payable and accrued liabilities approximated
their carrying values because of the short-term nature of these
accounts. Convertible debt has a carrying value of $ 1,762,983 and a
fair value of $ 2,130,000.
4. INVESTMENT IN UNCONSOLIDATED AFFILIATE
In 1993, the Company entered into an agreement with Tamarack Storage
Devices, Inc. ("Tamarack") pursuant to which The Company had the right
to acquire up to 50 percent of Tamarack's common stock representing
37.2 percent of the issued and outstanding voting securities of
Tamarack. Under the terms of the agreement, the Company invested
$3,000,000 in the aggregate in Tamarack and had accounted for this
investment under the equity method. The goodwill recorded with this
investment, which represented the excess of the Company's investment
over the underlying net assets of Tamarack, was $1,883,995. Such amount
was being amortized over ten years and is reported in the statement of
operations as Equity in Loss from Unconsolidated Affiliate.
Amortization expense related to such goodwill for the fiscal years
ended December 31, 1994 and 1995 was $197,884 and $148,413,
respectively. The Company issued 32,000 shares of common stock (valued
at $109,120) for advisory services received in connection with the
acquisition. In 1994 the Company loaned Tamarack $1,500,000 with
interest payable at 6 percent.
In 1995, Tamarack received a commitment from Projectavision to fund its
cash needs through December 31, 1995 to continue its operations as then
constituted. Pursuant to this $94,240 was advanced to Tamarack.
The Company recorded a reserve against its investment in Tamarack of
$300,000 in 1994 and at December 31, 1995 the Company reduced its
investment in and advances to Tamarack to zero recording an additional
reserve of $2,129,252 due to Tamarack's inability, to date, to
commercialize its holographic storage technology and its current lack
of prospects. In addition, Tamarack continues to incur losses, and its
viability to achieve profitable operations is doubtful.
In November, 1996, the Company loaned $ 100,000 to Tamarack. This
amount is included in other current assets and is to be repaid in March
1997 following receipt of funds from a government agency.
5. PROVISION FOR ALLOWANCE ON ADVANCES
The Company has made advances through July 31, 1995 in contemplation of
an investment in a high technology company. The president of the
Company is related to an individual who is an executive officer and
director of Projectavision. Such advances aggregated $298,426 and had
been fully reserved for at December 31, 1995. In 1996 $ 109,166 of
these funds were paid to the Company as a final settlement of the
amounts advanced.
6. ASSIGNMENT AGREEMENT
On March 19, 1990, an officer/stockholder of the Company entered into
an assignment agreement with the Company whereby all rights, title and
interest to the projection technology were assigned to the Company. The
rights, title and interest to the United States patent and foreign
patents relating to the projector technology under development by the
Company were originally applied for by this officer/stockholder.
7. EMPLOYMENT AGREEMENTS
The Company has entered into employment agreements with two of its
officers and directors. Aggregated minimum compensation under these
agreements will be $360,000 per year through 1997. For 1994, 1995, and
1996 salary expense was approximately $330,000, $527,000, and $577,453
respectively.
F-9
PROJECTAVISION, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------
8. COMMON STOCK
In 1994, the Company received gross proceeds of $1,575,000 in
connection with the sale of 200,000 shares of its common stock in a
private placement effected pursuant to Regulation S of the Securities
Act of 1933, as amended (Registration S). In addition, the Company
received an additional $1,381,250 of gross proceeds in connection with
the sale of 250,000 shares of its common stock pursuant to a private
placement effected under Regulation S. In connection with this private
placement, the Company also issued an additional 31,000 shares of its
common stock in payment of private placements costs. Finally, the
Company received gross proceeds of $3,740,167 in connection with the
sale of 920,860 shares of common stock in a series of private
placements effected pursuant to Regulation S of the Securities Act of
1933, as amended (Registration S).
In April 1995 the Company issued 83,030 shares of common stock for
professional services.
9. PREFERRED STOCK
The Series B Convertible Preferred Stock provides for cumulative annual
stock dividends (payable in common shares) of 8 percent of the
liquidation value of $5 per share (for a total of $2,173,335 including
shares issued on May 15, 1992 as discussed below) to be paid
semiannually and is convertible to one share of common stock, subject
to adjustment. In 1994, 27,887 shares of common stock were paid as
stock dividends on Series B Convertible Preferred Stock. This stock may
be redeemed by the Company if certain conditions are met for $1.00 per
share.
In 1996, the Company issued 7,500 shares of Series C Preferred Stock
for $7,500,000, resulting in net proceeds to The Company of $7,000,000
after fees. The Series C Preferred Stock converts into shares of Common
Stock at a 25% discount of the average closing bid price of the Common
Stock for the five (5) trading days immediately preceding the date of
conversion. The holder of the Series C Preferred Stock has the right to
convert into Common Stock as follows: 25% can be converted on or after
November 1, 1996: 25% may be converted on or after January 1, 1997: 25%
may be converted on or after March 1, 1997; and 25% may be converted on
or after May 1, 1997. The Company, in accordance with the terms and
conditions of the sale of the Series C Preferred Stock, registered the
shares of Common Stock into which the Series C Preferred Stock is
convertible in the third quarter of 1996. The Series C Preferred Stock
pays dividends semi-annually, seven (7) business days after each of
December 31st and June 30th of each year, which may be in cash or
shares of Common Stock at the election of The Company. The dividend
rate is 3% per annum of the liquidation value of $1,000.00 per share
until and through June 30, 1997; 6% per annum from July 1, 1997 through
June 30, 1998; and 8% per annum from July 1, 1998 and thereafter. The
Company recognized a dividend on the Series C Preferred Stock based on
the annualized pro-rata amount of the 25% discount on the conversion
into common stock and on the increase in the dividend rate. In January
1997, 3,750 of the Company's Series C Preferred Stock have been
converted into 1,948,188 shares of Common Stock.
In January of 1997, the Company issued an aggregate of 35,000 shares of
6% Series D convertible preferred stock to two foreign institutional
investors for an aggregate purchase price of $ 3,500,000, resulting in
net proceeds to the Company of $ 3,500,000. Each share of Series D
Preferred Stock is convertible, at the option of the holder, into
shares of the Company's Common Stock as follows: 8,750 shares on or
after May 1, 1997; 8,750 shares on or after July 1, 1997; 8,750 shares
on or after September 1, 1997; and 8,750 shares on or after November 1,
1997. The Series D Preferred Stock is convertible into Common Stock at
a 25% discount to the then current market price of the Company's Common
Stock at the time of conversion (the "Series D Conversion Price");
provided, however, that in the event that the Series D Conversion price
is less than $ 2.00 per share, then under no circumstances can shares
of Series D Preferred Stock be converted into the Company's Common
Stock until such time as the Series D Conversion Price exceeds $ 2.00
per share, subject to the following: (i) in the event that the Company
fails to either ship 2,500 projectors or generate $ 12,500,000
projector revenues during the period January 1, 1997 through June 30,
1997, then the Series D Conversion Price shall be reduced by $ 0.50, or
(ii) in the event that the Company fails to ship 2,500 projectors and
generate $ 12,500,000 of projector revenues during the period July 1,
1997 through December 31, 1997, then the Series D Conversion Price
shall be reduced by $ 0.50.
F-10
PROJECTAVISION, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------
10. CONVERTIBLE DEBT
In February 1996, the Company completed an offshore private placement
of $10,000,000 of convertible debt resulting in net proceeds to the
Company of $9,500,000. The convertible debt bears interest at the rate
of 8% per annum and pays interest quarterly in arrears on any unpaid or
unconverted debt. To the extent not previously converted, the
convertible debt is due in January 1999, and may be repaid in cash or
common stock of the Company at the sole option of the Company. All
conversions of convertible debt into common stock are based upon a 25%
discount of the price of the Company's common stock for five
consecutive trading days immediately prior to the date of conversion.
In April 1996 the Company issued 1,456,329 shares of its common stock
and paid $4,357,000 in cash in exchange for retiring $7.2 million in
convertible debt. In July 1996, the Company issued 161,616 shares of
its common stock and paid $250,000 in cash in exchange for retiring
$0.5 million of convertible debt. In October 1996, the Company issued
155,000 shares of its common stock and paid $ 351,250 in cash in
exchange for retiring $0.7 million of convertible debt. The Company
recognized as interest expense based on the annualized pro-rata amount
of the 25% discount on the conversion into common stock and on the
annualized pro-rata share of the placement costs. In January 1997,
the Company retired $ 100,000 of convertible debt for cash. There
currently remains $1.5 million in convertible debt outstanding.
11. STOCK OPTION PLANS
Non-qualified Option Plan - The Company has reserved 5,000,000 shares
of common stock for issuance upon exercise of options under a
non-qualified stock option plan adopted in February 1990 and amended in
June 1990, July 1990, and November 1993. All options granted under this
plan have been granted at fair market value at the date of grant. The
following is a summary of non-qualified option plan activity for the
three years ended December 31, 1996:
1994 1995 1996
Outstanding at January 1 1,298,333 2,455,333 2,210,833
--------- --------- ---------
Granted 1,260,500 68,000 2,682,500
Expired - - -
Canceled - (312,500) (660,125)
Exercised ( 103,500) - ( 24,375)
--------- ---------- ----------
Outstanding at December 31 2,455,333 2,210,833 4,208,833
========= ========== ==========
Available for grant at December 31 2,544,667 2,789,167 791,167
========= ========== ==========
Weighted average option exercise price information for the years 1996,
1995, and 1994 follows:
1994 1995 1996
Outstanding at January 1 3.61 3.63 3.56
Granted 3.63 2.70 4.34
Expired - - -
Canceled - 2.50 3.56
Exercised 3.62 - 0.81
Outstanding at December 31 3.63 3.56 4.06
Exercisable at December 31 3.57 3.56 3.95
Significant option groups outstanding at December 31, 1996 and related
weighted average price and life information follows:
Grant Date Options Outstanding Options Exercisable Exercise Price Remaining Life (Years)
3/12/96 2,000,000 666,666 4.375 7
10/21/94 625,000 625,000 4.625 5
F-11
PROJECTAVISION, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------
11. STOCK OPTION PLANS (Continued)
The weighted fair value at date of grant for options granted in 1996
and 1995 was $ 2.59 and $ 3.03 per option, respectively. The fair value
of options at date of grant was estimated based on the opinion of such
fair value attributed by a receipt of one of the grants with the
following weighted average assumptions:
1995 1996
Expected life (Years) 5 5
Interest Rate 6.25% 6.25%
Volatility 89% 89%
Dividend Yield 0% 0%
Stock-based compensation costs did not impact pretax income or earnings
per share in 1996 and 1995. These costs would have been increased by
$.4 million, or ($ 0.02) per share, in 1996 and $ 10,000, or
($.00) per share, in 1995 had the fair values of the options been
recognized as compensation expense on a straight line basis over the
vesting period of the grant.
Incentive Option Plan - In February 1990, the 1988 Incentive Stock
Option and Appreciation Plan was terminated and a new plan, as amended
in June 1990, July 1990, and November 1993 was adopted under which
options to purchase 1,000,000 shares of common stock have been
reserved. The incentive option plan provides for the granting of
incentive stock options (ISOS) at an exercise price not less than the
fair market value of the common stock on the date the option is
granted. ISOS may not be granted to an individual to the extent that,
in the calendar year in which such ISOS first become exercisable, the
shares subject such ISOS have a fair market value on the date of grant
in excess of $100,000. No option may be granted after February 20,
2000, and no option may be outstanding for more than ten years after
its grant. As of December 31, 1996, no options have been granted under
the Plan.
12. RELATED PARTY TRANSACTIONS
In 1989 advances totaling $10,833 were made to a principal stockholder
of DKY and were outstanding at December 31,1996.
13. INCOME TAXES
As of December 31, 1995 and 1996, the composition of the Company's net
deferred taxes was as follows:
1995 1996
Deferred tax assets $ 6,801,000 $ 8,400,000
Less valuation allowance (6,801,000) (8,400,000)
---------- ------------
Net $ - $ -
========== ============
Deferred tax assets principally result from the availability of net
operating and capital loss carry-forwards to offset income earned in
future years. The offsetting valuation allowance reduces total deferred
tax assets to an amount management believes will likely be realized.
At December 31, 1996, the Company had tax net operating and capital
loss carry-forwards of approximately $21,000,000, which expire in the
years 2003 through 2010. The utilization of tax net operating and
capital losses may be subject to certain limitations.
14. COMMITMENTS AND CONTINGENCIES
On November 18, 1994 the Company entered into a non exclusive,
non-transferable license without a right to sub-license, except to
related companies, with Samsung Electronics Co. pursuant to which the
Company gave to Samsung the right to use the Company's patented
depixelization technology (as defined) in connection with the
manufacturing and marketing of LCD projectors. The license is
co-terminus with the life of the patents and patent applications
relating to the proprietary rights underlying the license.
F-12
PROJECTAVISION, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------
14. COMMITMENTS AND CONTINGENCIES (Continued)
The future minimum rental commitments as of December 31, 1996 are as
follows:
Year Amount
---- ------
1997 $ 257,554
1998 21,462
--------
$ 279,016
=========
Rent expense for the years ended December 31, 1995 and 1996 was
$204,832 and $209,695, respectively.
In 1994 a legal action was brought against the Company and various
other parties by several former employees and a former consultant of
Tamarack. The complaint alleged wrongful termination of employment and
related charges. This complaint was settled in February, 1996 at no
cost to the Company.
In 1995 a legal action was brought against the Company, certain members
of the Board of Directors, and an employee of the Company by a former
officer and employee of the Company. The complaint alleges, among other
actions, breach of employment and patent assignment agreements.
In 1995 the Company was served with class action law suits, which have
now been consolidated, alleging various federal securities laws
violations primarily in connection with the Company's public
disclosures. In July, 1996 the consolidated class action lawsuit was
denied by the court.
In 1996 two of the eleven purchasers of the convertible debt commenced
a lawsuit against the Company seeking an order to have their debt
converted into common stock. One of the two purchasers settled their
lawsuit with the Company in October, 1996. The litigation with the
other debt holder remains outstanding.
In 1996, a suit was filed by a individual investor against the Company
and Marvin Maslow alleging fraudulent inducement in connection with the
plaintiff's purchase of the Company's securities.
In all of the above actions, the Company's management, based upon
discussions with counsel, believe that they have a meritorious defense
against these claims and intend a vigorous defense against these
claims. The Company's management believes that the outcome of these
matters will not have a material adverse effect on its financial
position or results of operations.
Please refer to Item 3. Legal Proceedings on pages 15 through 18 for
further details.
F-13
SIGNATURES
In accordance with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
executed on this 26th day of March, 1997.
PROJECTAVISION, INC.
By:/s/ Martin Holleran
---------------------------
Martin Holleran, President
Chief Executive Officer and
Director
In accordance with the Exchange Act this report has been signed below by
the following persons in the capacities and on the dates indicated:
Signature Title Date
- --------- ----- ----
/s/ Marvin Maslow Chairman of the Board March 26, 1997
- ------------------------- of Directors
Marvin Maslow
/s/ Martin Holleran President, Chief March 26, 1997
- ------------------------- Executive Officer and
Martin Holleran Director
/s/ Jules Zimmerman Chief Financial March 26, 1997
- ------------------------- Officer, Secretary and
Jules Zimmerman Director
/s/ Martin D. Fife Director March 26, 1997
- -------------------------
Martin D. Fife
/s/ Richard S. Hickok Director March 26, 1997
- -------------------------
Richard S. Hickok
/s/ Dr. Craig I. Fields Director March 26, 1997
- -------------------------
Dr. Craig I. Fields
/s/ Arthur Lipper III Director March 26, 1997
- -----------------------
Arthur Lipper III
/s/ Sherman Langer Director March 26, 1997
- -----------------------
Sherman Langer